{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:53:25Z","timestamp":1794966805000,"version":"4.9.1"},"reference-count":322,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100022016","name":"College of Graduate Studies, United Arab Emirates University","doi-asserted-by":"publisher","award":["start up: G0000429"],"award-info":[{"award-number":["start up: G0000429"]}],"id":[{"id":"10.13039\/501100022016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022016","name":"College of Graduate Studies, United Arab Emirates University","doi-asserted-by":"publisher","award":["SURE PLUS fund G00004809"],"award-info":[{"award-number":["SURE PLUS fund G00004809"]}],"id":[{"id":"10.13039\/501100022016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006014","name":"College of Medicine and Health Sciences, United Arab Emirates University","doi-asserted-by":"publisher","award":["UPAR fund G00004634"],"award-info":[{"award-number":["UPAR fund G00004634"]}],"id":[{"id":"10.13039\/501100006014","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mubadala","award":["Mubadala-UAEU grant G00004894"],"award-info":[{"award-number":["Mubadala-UAEU grant G00004894"]}],"id":[{"id":"https:\/\/ror.org\/03t89te61","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06470-x","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T06:23:06Z","timestamp":1745907786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Human papilloma virus (HPV) mediated cancers: an insightful update"],"prefix":"10.1186","volume":"23","author":[{"given":"Sadaf Khursheed","family":"Baba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad Shahdad Eissa","family":"Alblooshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Al Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad A.","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayaz","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzafar A.","family":"Macha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Kalim","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid A.","family":"Houry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz A.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Al Menhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-2421","authenticated-orcid":false,"given":"Sameer","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"11","key":"6470_CR1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","volume":"41","author":"HW Chesson","year":"2014","unstructured":"Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660\u20134.","journal-title":"Sex Transm Dis"},{"issue":"3","key":"6470_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/GRF.0b013e31825caa36","volume":"55","author":"JK Hathaway","year":"2012","unstructured":"Hathaway JK. HPV: diagnosis, prevention, and treatment. Clin Obstet Gynecol. 2012;55(3):671\u201380.","journal-title":"Clin Obstet Gynecol"},{"issue":"5","key":"6470_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/v16050680","volume":"16","author":"JE Jensen","year":"2024","unstructured":"Jensen JE, Becker GL, Jackson JB, Rysavy MB. Human papillomavirus and associated cancers: a review. Viruses. 2024;16(5):680.","journal-title":"Viruses"},{"issue":"4","key":"6470_CR4","first-page":"198","volume":"66","author":"B Sehnal","year":"2017","unstructured":"Sehnal B, Rozsypal H, Nip\u010dov\u00e1 M, Sl\u00e1ma J. The prevalence, incidence, persistence and transmission ways of human papillomavirus infection (HPV). Epidemiol Mikrobiol Imunol. 2017;66(4):198\u2013209.","journal-title":"Epidemiol Mikrobiol Imunol"},{"issue":"3","key":"6470_CR5","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.3390\/ijms23031818","volume":"23","author":"DA Har\u0119\u017ca","year":"2022","unstructured":"Har\u0119\u017ca DA, Wilczy\u0144ski JR, Paradowska E. Human papillomaviruses as infectious agents in gynecological cancers. Oncogenic properties of viral proteins. Int J Mol Sci. 2022;23(3):1818.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6470_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s10147-023-02340-y","volume":"28","author":"N Egawa","year":"2023","unstructured":"Egawa N. Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body. Int J Clin Oncol. 2023;28(8):956\u201364.","journal-title":"Int J Clin Oncol"},{"key":"6470_CR7","doi-asserted-by":"publisher","first-page":"552028","DOI":"10.3389\/fpubh.2020.552028","volume":"8","author":"AJ Kombe Kombe","year":"2020","unstructured":"Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health. 2020;8:552028.","journal-title":"Front Public Health"},{"issue":"9","key":"6470_CR8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","volume":"92","author":"HZ Hausen","year":"2000","unstructured":"Hausen HZ. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92(9):690\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"6470_CR9","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.biocel.2007.07.004","volume":"39","author":"G Boulet","year":"2007","unstructured":"Boulet G, Horvath C, Vanden Broeck D, Sahebali S, Bogers J. Human papillomavirus: E6 and E7 oncogenes. Int J Biochem Cell Biol. 2007;39(11):2006\u201311.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"6470_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc2050","volume":"7","author":"CB Woodman","year":"2007","unstructured":"Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007;7(1):11\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"6470_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1067\/mob.2003.164","volume":"188","author":"C Mao","year":"2003","unstructured":"Mao C, Hughes JP, Kiviat N, Kuypers J, Lee SK, Adam DE, et al. Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol. 2003;188(3):677\u201384.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6470_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41579-021-00617-5","volume":"20","author":"AA McBride","year":"2022","unstructured":"McBride AA. Human papillomaviruses: diversity, infection and host interactions. Nat Rev Microbiol. 2022;20(2):95\u2013108.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"6470_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2169","volume":"31","author":"AK Aranda-Rivera","year":"2021","unstructured":"Aranda-Rivera AK, Cruz-Gregorio A, Briones-Herrera A, Pedraza-Chaverri J. Regulation of autophagy by high- and low-risk human papillomaviruses. Rev Med Virol. 2021;31(2): e2169.","journal-title":"Rev Med Virol"},{"issue":"1","key":"6470_CR14","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41598-024-51594-7","volume":"14","author":"A Seyoum","year":"2024","unstructured":"Seyoum A, Seyoum B, Gure T, Alemu A, Alemayehu DH, Alemu A, et al. High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia. Sci Rep. 2024;14(1):958. https:\/\/doi.org\/10.1038\/s41598-024-51594-7.","journal-title":"Sci Rep"},{"issue":"11","key":"6470_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Mu\u00f1oz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87(11):796\u2013802.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"6470_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrc1973","volume":"6","author":"R Roden","year":"2006","unstructured":"Roden R, Wu TC. How will HPV vaccines affect cervical cancer? Nat Rev Cancer. 2006;6(10):753\u201363.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"6470_CR17","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/pathogens12121380","volume":"12","author":"M Jain","year":"2023","unstructured":"Jain M, Yadav D, Jarouliya U, Chavda V, Yadav AK, Chaurasia B, et al. Epidemiology, molecular pathogenesis, immuno-pathogenesis, immune escape mechanisms and vaccine evaluation for HPV-associated carcinogenesis. Pathogens. 2023;12(12):1380.","journal-title":"Pathogens"},{"key":"6470_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2013.11.002","volume":"26","author":"M Tommasino","year":"2014","unstructured":"Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol. 2014;26:13\u201321.","journal-title":"Semin Cancer Biol"},{"key":"6470_CR19","doi-asserted-by":"publisher","first-page":"102140","DOI":"10.1016\/j.canep.2022.102140","volume":"78","author":"Y Lu","year":"2022","unstructured":"Lu Y, Xie Z, Luo G, Yan H, Qian HZ, Fu L, et al. Global burden of oropharyngeal cancer attributable to human papillomavirus by anatomical subsite and geographic region. Cancer Epidemiol. 2022;78:102140.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"6470_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","volume":"14","author":"AR Kreimer","year":"2005","unstructured":"Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467\u201375.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"6470_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1\u201317.","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"6470_CR22","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609\u201316.","journal-title":"Lancet Glob Health"},{"key":"6470_CR23","first-page":"794","volume":"36","author":"HZ Hausen","year":"1976","unstructured":"Hausen HZ. Condylomata acuminata and human genital cancer. Cancer Res. 1976;36:794.","journal-title":"Cancer Res"},{"issue":"5","key":"6470_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"HZ Hausen","year":"2002","unstructured":"Hausen HZ. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"9686","key":"6470_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmer\u00f3n J, Wheeler CM, Chow SN, Apter D, et al. Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301\u201314.","journal-title":"Lancet"},{"issue":"9686","key":"6470_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(09)61247-2","volume":"374","author":"KB Michels","year":"2009","unstructured":"Michels KB, Hausen HZ. HPV vaccine for all. Lancet. 2009;374(9686):268\u201370.","journal-title":"Lancet"},{"issue":"1","key":"6470_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-024-02083-w","volume":"10","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qiu K, Ren J, Zhao Y, Cheng P. Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use. Signal Transduct Target Ther. 2025;10(1):44.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"6470_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/vaccines10071054","volume":"10","author":"Y Tao","year":"2022","unstructured":"Tao Y, Shao H, Zhang T, Pu J, Tang C. Factors influencing men\u2019s attitudes toward HPV vaccination in males included in the chinese national immunization program. Vaccines. 2022;10(7):1054.","journal-title":"Vaccines"},{"issue":"8","key":"6470_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/v9080229","volume":"9","author":"S Shanmugasundaram","year":"2017","unstructured":"Shanmugasundaram S, You J. Targeting persistent human papillomavirus infection. Viruses. 2017;9(8):229.","journal-title":"Viruses"},{"issue":"10451","key":"6470_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024;404(10451):435\u201344.","journal-title":"Lancet"},{"key":"6470_CR31","unstructured":"Bruni L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J, et al. ICO\/IARC information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in the world Summary Report. 2019;17(6)."},{"issue":"10","key":"6470_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/v9100293","volume":"9","author":"S Alizon","year":"2017","unstructured":"Alizon S, Murall CL, Bravo IG. Why human papillomavirus acute infections matter. Viruses. 2017;9(10):293.","journal-title":"Viruses"},{"key":"6470_CR33","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171268","author":"SC Tan","year":"2018","unstructured":"Tan SC, Ismail MP, Duski DR, Othman NH, Ankathil R. Prevalence and type distribution of human papillomavirus (HPV) in Malaysian women with and without cervical cancer: an updated estimate. Biosci Rep. 2018. https:\/\/doi.org\/10.1042\/BSR20171268.","journal-title":"Biosci Rep"},{"key":"6470_CR34","first-page":"56","volume":"74","author":"B Filipi\u0107","year":"2024","unstructured":"Filipi\u0107 B, Rapaji\u0107-Moran I, Nikoli\u0107 I, Olja\u010di\u0107 S, Mandi\u0107 A. Human papillomaviruses and cervical cancer from the perspective of the World Health Organisation initiative for cervical cancer elimination. Arch Pharm. 2024;74:56\u201375.","journal-title":"Arch Pharm"},{"key":"6470_CR35","volume-title":"Cervical cancer-a global public health treatise","author":"AV Tarnju","year":"2021","unstructured":"Tarnju AV. Global burden of cervical cancer. In: Rajkumar R, editor. Cervical cancer-a global public health treatise. London: IntechOpen; 2021."},{"issue":"1","key":"6470_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"6470_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.semradonc.2021.04.001","volume":"31","author":"N Scott-Wittenborn","year":"2021","unstructured":"Scott-Wittenborn N, Fakhry C. Epidemiology of HPV related malignancies. Semin Radiat Oncol. 2021;31(4):286\u201396.","journal-title":"Semin Radiat Oncol"},{"issue":"6","key":"6470_CR38","doi-asserted-by":"publisher","first-page":"696","DOI":"10.5858\/arpa.2017-0565-RA","volume":"142","author":"MC Nweke","year":"2018","unstructured":"Nweke MC, Okolo CA, Daous Y, Esan OA. Challenges of human papillomavirus infection and associated diseases in low-resource countries. Arch Pathol Lab Med. 2018;142(6):696\u20139.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"6470_CR39","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197\u2013206.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"6470_CR40","doi-asserted-by":"publisher","first-page":"e2219","DOI":"10.1002\/rmv.2219","volume":"31","author":"M Farahmand","year":"2021","unstructured":"Farahmand M, Monavari SH, Tavakoli A. Prevalence and genotype distribution of human papillomavirus infection in different anatomical sites among men who have sex with men: a systematic review and meta-analysis. Rev Med Virol. 2021;31(6):e2219.","journal-title":"Rev Med Virol"},{"issue":"3","key":"6470_CR41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/PPO.0000000000000115","volume":"21","author":"AP Stein","year":"2015","unstructured":"Stein AP, Saha S, Kraninger JL, Swick AD, Yu M, Lambert PF, et al. Prevalence of human papillomavirus in oropharyngeal cancer: a systematic review. Cancer J. 2015;21(3):138\u201346.","journal-title":"Cancer J"},{"key":"6470_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","volume":"47","author":"B Serrano","year":"2018","unstructured":"Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol. 2018;47:14\u201326.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"6470_CR43","doi-asserted-by":"publisher","first-page":"e2337","DOI":"10.1002\/rmv.2337","volume":"33","author":"M Wierzbicka","year":"2023","unstructured":"Wierzbicka M, San Giorgi MRM, Dikkers FG. Transmission and clearance of human papillomavirus infection in the oral cavity and its role in oropharyngeal carcinoma - a review. Rev Med Virol. 2023;33(1):e2337.","journal-title":"Rev Med Virol"},{"issue":"6","key":"6470_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3892\/etm.2020.9316","volume":"20","author":"A Petca","year":"2020","unstructured":"Petca A, Borislavschi A, Zvanca ME, Petca RC, Sandru F, Dumitrascu MC. Non-sexual HPV transmission and role of vaccination for a better future (Review). Exp Ther Med. 2020;20(6):186.","journal-title":"Exp Ther Med"},{"issue":"1","key":"6470_CR45","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/22221751.2019.1637072","volume":"8","author":"NM Cladel","year":"2019","unstructured":"Cladel NM, Jiang P, Li JJ, Peng X, Cooper TK, Majerciak V, et al. Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models. Emerg Microbes Infect. 2019;8(1):1108\u201321.","journal-title":"Emerg Microbes Infect"},{"key":"6470_CR46","doi-asserted-by":"publisher","first-page":"103222","DOI":"10.1016\/j.ebiom.2021.103222","volume":"64","author":"E Boccardo","year":"2021","unstructured":"Boccardo E. New approaches for infective HPV detection, quantification and inactivation: preventing accidental virus transmission in medical settings. EBioMedicine. 2021;64:103222.","journal-title":"EBioMedicine"},{"issue":"9","key":"6470_CR47","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.3390\/ijms23094943","volume":"23","author":"L Yu","year":"2022","unstructured":"Yu L, Majerciak V, Zheng ZM. HPV16 and HPV18 genome structure, expression, and post-transcriptional regulation. Int J Mol Sci. 2022;23(9):4943.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"6470_CR48","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2217\/fmb.10.107","volume":"5","author":"SV Graham","year":"2010","unstructured":"Graham SV. Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol. 2010;5(10):1493\u2013506.","journal-title":"Future Microbiol"},{"key":"6470_CR49","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1017\/erm.2021.18","volume":"23","author":"G Bletsa","year":"2021","unstructured":"Bletsa G, Zagouri F, Amoutzias GD, Nikolaidis M, Zografos E, Markoulatos P, et al. Genetic variability of the HPV16 early genes and LCR. Present and future perspectives. Expert Rev Mol Med. 2021;23:e19.","journal-title":"Expert Rev Mol Med"},{"key":"6470_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-4614-0980-9_18","volume":"726","author":"CB Buck","year":"2012","unstructured":"Buck CB, Trus BL. The papillomavirus virion: a machine built to hide molecular Achilles\u2019 heels. Adv Exp Med Biol. 2012;726:403\u201322.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"6470_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/pathogens9060483","volume":"9","author":"M Mac","year":"2020","unstructured":"Mac M, Moody CA. Epigenetic regulation of the human papillomavirus life cycle. Pathogens. 2020;9(6):483.","journal-title":"Pathogens"},{"issue":"2","key":"6470_CR52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41416-024-02655-1","volume":"131","author":"H Tabatabaeian","year":"2024","unstructured":"Tabatabaeian H, Bai Y, Huang R, Chaurasia A, Darido C. Navigating therapeutic strategies: HPV classification in head and neck cancer. Br J Cancer. 2024;131(2):220\u201330.","journal-title":"Br J Cancer"},{"issue":"17","key":"6470_CR53","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"SV Graham","year":"2017","unstructured":"Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017;131(17):2201\u201321.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"6470_CR54","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1128\/JVI.00330-13","volume":"87","author":"AB Raff","year":"2013","unstructured":"Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, et al. The evolving field of human papillomavirus receptor research: a review of binding and entry. J Virol. 2013;87(11):6062\u201372.","journal-title":"J Virol"},{"issue":"1 Suppl","key":"6470_CR55","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ygyno.2010.04.004","volume":"118","author":"JT Schiller","year":"2010","unstructured":"Schiller JT, Day PM, Kines RC. Current understanding of the mechanism of HPV infection. Gynecol Oncol. 2010;118(1 Suppl):S12\u20137.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"6470_CR56","doi-asserted-by":"publisher","first-page":"e1002519","DOI":"10.1371\/journal.ppat.1002519","volume":"8","author":"Z Surviladze","year":"2012","unstructured":"Surviladze Z, Dziduszko A, Ozbun MA. Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog. 2012;8(2):e1002519.","journal-title":"PLoS Pathog"},{"issue":"1","key":"6470_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2010.04.007","volume":"403","author":"CY Abban","year":"2010","unstructured":"Abban CY, Meneses PI. Usage of heparan sulfate, integrins, and FAK in HPV16 infection. Virology. 2010;403(1):1\u201316.","journal-title":"Virology"},{"issue":"3","key":"6470_CR58","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1128\/jvi.71.3.2449-2456.1997","volume":"71","author":"M Evander","year":"1997","unstructured":"Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol. 1997;71(3):2449\u201356.","journal-title":"J Virol"},{"issue":"18","key":"6470_CR59","doi-asserted-by":"publisher","first-page":"8940","DOI":"10.1128\/JVI.00724-06","volume":"80","author":"TD Culp","year":"2006","unstructured":"Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol. 2006;80(18):8940\u201350.","journal-title":"J Virol"},{"issue":"24","key":"6470_CR60","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1128\/JVI.77.24.13125-13135.2003","volume":"77","author":"S Shafti-Keramat","year":"2003","unstructured":"Shafti-Keramat S, Handisurya A, Kriehuber E, Meneguzzi G, Slupetzky K, Kirnbauer R. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol. 2003;77(24):13125\u201335.","journal-title":"J Virol"},{"issue":"8","key":"6470_CR61","doi-asserted-by":"publisher","first-page":"e43519","DOI":"10.1371\/journal.pone.0043519","volume":"7","author":"AW Woodham","year":"2012","unstructured":"Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, Brand HE, et al. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS ONE. 2012;7(8):e43519.","journal-title":"PLoS ONE"},{"issue":"13","key":"6470_CR62","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1128\/JVI.00519-13","volume":"87","author":"A Dziduszko","year":"2013","unstructured":"Dziduszko A, Ozbun MA. Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J Virol. 2013;87(13):7502\u201315.","journal-title":"J Virol"},{"issue":"16","key":"6470_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1128\/JVI.00307-17","volume":"91","author":"G Sch\u00e4fer","year":"2017","unstructured":"Sch\u00e4fer G, Graham LM, Lang DM, Blumenthal MJ, Bergant Maru\u0161i\u010d M, Katz AA. Vimentin modulates infectious internalization of human papillomavirus 16 pseudovirions. J Virol. 2017;91(16):17.","journal-title":"J Virol"},{"issue":"6","key":"6470_CR64","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JVI.02906-12","volume":"87","author":"KD Scheffer","year":"2013","unstructured":"Scheffer KD, Gawlitza A, Spoden GA, Zhang XA, Lambert C, Berditchevski F, et al. Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol. 2013;87(6):3435\u201346.","journal-title":"J Virol"},{"key":"6470_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2016.10.015","volume":"231","author":"S DiGiuseppe","year":"2017","unstructured":"DiGiuseppe S, Bienkowska-Haba M, Guion LG, Sapp M. Cruising the cellular highways: how human papillomavirus travels from the surface to the nucleus. Virus Res. 2017;231:1\u20139.","journal-title":"Virus Res"},{"issue":"7","key":"6470_CR66","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1128\/JVI.03222-12","volume":"87","author":"PM Day","year":"2013","unstructured":"Day PM, Thompson CD, Schowalter RM, Lowy DR, Schiller JT. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol. 2013;87(7):3862\u201370.","journal-title":"J Virol"},{"issue":"18","key":"6470_CR67","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1073\/pnas.1302164110","volume":"110","author":"A Lipovsky","year":"2013","unstructured":"Lipovsky A, Popa A, Pimienta G, Wyler M, Bhan A, Kuruvilla L, et al. Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci U S A. 2013;110(18):7452\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"6470_CR68","doi-asserted-by":"publisher","first-page":"e01777","DOI":"10.1128\/mBio.01777-14","volume":"5","author":"W Zhang","year":"2014","unstructured":"Zhang W, Kazakov T, Popa A, DiMaio D. Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires \u03b3-secretase activity. MBio. 2014;5(5):e01777-e1814.","journal-title":"MBio"},{"issue":"3","key":"6470_CR69","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/vaccines7030102","volume":"7","author":"L Urbanelli","year":"2019","unstructured":"Urbanelli L, Buratta S, Tancini B, Sagini K, Delo F, Porcellati S, et al. The role of extracellular vesicles in viral infection and transmission. Vaccines (Basel). 2019;7(3):102.","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"6470_CR70","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3390\/v13091846","volume":"13","author":"A Warburton","year":"2021","unstructured":"Warburton A, Della Fera AN, McBride AA. Dangerous liaisons: long-term replication with an extrachromosomal HPV genome. Viruses. 2021;13(9):1846.","journal-title":"Viruses"},{"issue":"19","key":"6470_CR71","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1128\/JVI.77.19.10186-10201.2003","volume":"77","author":"K Middleton","year":"2003","unstructured":"Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T, et al. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol. 2003;77(19):10186\u2013201.","journal-title":"J Virol"},{"issue":"54","key":"6470_CR72","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.1038\/sj.onc.1204860","volume":"20","author":"K M\u00fcnger","year":"2001","unstructured":"M\u00fcnger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene. 2001;20(54):7888\u201398.","journal-title":"Oncogene"},{"issue":"2","key":"6470_CR73","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/CMR.05028-11","volume":"25","author":"MA Stanley","year":"2012","unstructured":"Stanley MA. Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev. 2012;25(2):215\u201322.","journal-title":"Clin Microbiol Rev"},{"issue":"2 Suppl","key":"6470_CR74","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","volume":"117","author":"M Stanley","year":"2010","unstructured":"Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010;117(2 Suppl):S5-10.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"6470_CR75","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550\u201360.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"6470_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1101\/cshperspect.a012997","volume":"5","author":"LT Chow","year":"2013","unstructured":"Chow LT, Broker TR. Human papillomavirus infections: warts or cancer? Cold Spring Harb Perspect Biol. 2013;5(7):17.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"6470_CR77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13027-024-00581-8","volume":"19","author":"A Letafati","year":"2024","unstructured":"Letafati A, Taghiabadi Z, Zafarian N, Tajdini R, Mondeali M, Aboofazeli A, et al. Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis. Infect Agent Cancer. 2024;19(1):30.","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"6470_CR78","doi-asserted-by":"publisher","first-page":"e0072924","DOI":"10.1128\/mbio.00729-24","volume":"15","author":"L Yu","year":"2024","unstructured":"Yu L, Majerciak V, Lobanov A, Mirza S, Band V, Liu H, et al. HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer. MBio. 2024;15(5):e0072924.","journal-title":"MBio"},{"issue":"10","key":"6470_CR79","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1128\/jvi.63.10.4417-4421.1989","volume":"63","author":"K M\u00fcnger","year":"1989","unstructured":"M\u00fcnger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 1989;63(10):4417\u201321.","journal-title":"J Virol"},{"issue":"5","key":"6470_CR80","doi-asserted-by":"publisher","first-page":"e0015122","DOI":"10.1128\/spectrum.00151-22","volume":"10","author":"H Liu","year":"2022","unstructured":"Liu H, Liang H, Li D, Wang M, Li Y. Association of cervical dysbacteriosis, HPV oncogene expression, and cervical lesion progression. Microbiol Spectr. 2022;10(5):e0015122.","journal-title":"Microbiol Spectr"},{"issue":"8","key":"6470_CR81","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41591-024-03014-6","volume":"30","author":"L Schreiberhuber","year":"2024","unstructured":"Schreiberhuber L, Barrett JE, Wang J, Redl E, Herzog C, Vavourakis CD, et al. Cervical cancer screening using DNA methylation triage in a real-world population. Nat Med. 2024;30(8):2251\u20137.","journal-title":"Nat Med"},{"issue":"10","key":"6470_CR82","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/cancers8100095","volume":"8","author":"V Tomai\u0107","year":"2016","unstructured":"Tomai\u0107 V. Functional roles of E6 and E7 oncoproteins in HPV-induced malignancies at diverse anatomical sites. Cancers (Basel). 2016;8(10):95.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"6470_CR83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0168-1702(02)00190-9","volume":"89","author":"K M\u00fcnger","year":"2002","unstructured":"M\u00fcnger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res. 2002;89(2):213\u201328.","journal-title":"Virus Res"},{"issue":"4","key":"6470_CR84","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.semradonc.2021.02.006","volume":"31","author":"PF Cosper","year":"2021","unstructured":"Cosper PF, Bradley S, Luo L, Kimple RJ. Biology of HPV mediated carcinogenesis and tumor progression. Semin Radiat Oncol. 2021;31(4):265\u201373.","journal-title":"Semin Radiat Oncol"},{"issue":"13","key":"6470_CR85","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1002\/j.1460-2075.1989.tb08594.x","volume":"8","author":"K M\u00fcnger","year":"1989","unstructured":"M\u00fcnger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Embo J. 1989;8(13):4099\u2013105.","journal-title":"Embo J"},{"issue":"10","key":"6470_CR86","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1073\/pnas.89.10.4549","volume":"89","author":"S Chellappan","year":"1992","unstructured":"Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci U S A. 1992;89(10):4549\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"6470_CR87","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1101\/gad.11.16.2101","volume":"11","author":"DL Jones","year":"1997","unstructured":"Jones DL, Alani RM, M\u00fcnger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 1997;11(16):2101\u201311.","journal-title":"Genes Dev"},{"issue":"11","key":"6470_CR88","first-page":"2323","volume":"13","author":"K Zerfass-Thome","year":"1996","unstructured":"Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-D\u00fcrr P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene. 1996;13(11):2323\u201330.","journal-title":"Oncogene"},{"issue":"11","key":"6470_CR89","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.18632\/oncotarget.1523","volume":"4","author":"K Munger","year":"2013","unstructured":"Munger K, Gwin TK, McLaughlin-Drubin ME. p16 in HPV-associated cancers. Oncotarget. 2013;4(11):1864\u20135.","journal-title":"Oncotarget"},{"issue":"5","key":"6470_CR90","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10147-016-1005-x","volume":"21","author":"D Sano","year":"2016","unstructured":"Sano D, Oridate N. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma. Int J Clin Oncol. 2016;21(5):819\u201326.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"6470_CR91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21641\/los.15.1.58","volume":"15","author":"P Sen","year":"2018","unstructured":"Sen P, Ganguly P, Ganguly N. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer. Oncol Lett. 2018;15(1):11\u201322.","journal-title":"Oncol Lett"},{"issue":"10","key":"6470_CR92","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1002\/cam4.1501","volume":"7","author":"Z Hu","year":"2018","unstructured":"Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7(10):5217\u201336.","journal-title":"Cancer Med"},{"issue":"2","key":"6470_CR93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ijc.11691","volume":"109","author":"S Duensing","year":"2004","unstructured":"Duensing S, M\u00fcnger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer. 2004;109(2):157\u201362.","journal-title":"Int J Cancer"},{"issue":"54","key":"6470_CR94","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1038\/sj.onc.1204869","volume":"20","author":"F Mantovani","year":"2001","unstructured":"Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001;20(54):7874\u201387.","journal-title":"Oncogene"},{"key":"6470_CR95","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.virusres.2016.11.003","volume":"231","author":"RA Katzenellenbogen","year":"2017","unstructured":"Katzenellenbogen RA. Activation of telomerase by HPVs. Virus Res. 2017;231:50\u20135.","journal-title":"Virus Res"},{"issue":"7267","key":"6470_CR96","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071\u20138.","journal-title":"Nature"},{"issue":"39","key":"6470_CR97","doi-asserted-by":"publisher","first-page":"19552","DOI":"10.1073\/pnas.1906102116","volume":"116","author":"J Sitz","year":"2019","unstructured":"Sitz J, Blanchet SA, Gameiro SF, Biquand E, Morgan TM, Galloy M, et al. Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response. Proc Natl Acad Sci U S A. 2019;116(39):19552\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"6470_CR98","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/v9080232","volume":"9","author":"CC Spriggs","year":"2017","unstructured":"Spriggs CC, Laimins LA. Human papillomavirus and the DNA damage response: exploiting host repair pathways for viral replication. Viruses. 2017;9(8):232.","journal-title":"Viruses"},{"issue":"17","key":"6470_CR99","doi-asserted-by":"publisher","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-09-0925","volume":"69","author":"N Spardy","year":"2009","unstructured":"Spardy N, Covella K, Cha E, Hoskins EE, Wells SI, Duensing A, et al. Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Cancer Res. 2009;69(17):7022\u20139.","journal-title":"Cancer Res"},{"issue":"9","key":"6470_CR100","doi-asserted-by":"publisher","first-page":"e75056","DOI":"10.1371\/journal.pone.0075056","volume":"8","author":"JW Park","year":"2013","unstructured":"Park JW, Shin MK, Pitot HC, Lambert PF. High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7\u2019s induction of DNA damage through its inactivation of pocket proteins. PLoS ONE. 2013;8(9):e75056.","journal-title":"PLoS ONE"},{"issue":"1","key":"6470_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PGP.0000000000000477","volume":"38","author":"CC Spriggs","year":"2019","unstructured":"Spriggs CC, Blanco LZ, Maniar KP, Laimins LA. Expression of HPV-induced DNA damage repair factors correlates with CIN progression. Int J Gynecol Pathol. 2019;38(1):1\u201310.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"6470_CR102","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/viro.1994.1456","volume":"203","author":"V Bouvard","year":"1994","unstructured":"Bouvard V, Matlashewski G, Gu ZM, Storey A, Banks L. The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology. 1994;203(1):73\u201380.","journal-title":"Virology"},{"key":"6470_CR103","doi-asserted-by":"publisher","first-page":"109716","DOI":"10.1016\/j.abb.2023.109716","volume":"745","author":"B Chen","year":"2023","unstructured":"Chen B, Zhao L, Yang R, Xu T. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis. Arch Biochem Biophys. 2023;745:109716.","journal-title":"Arch Biochem Biophys"},{"key":"6470_CR104","doi-asserted-by":"publisher","first-page":"103923","DOI":"10.1016\/j.micpath.2019.103923","volume":"139","author":"NE Ilahi","year":"2020","unstructured":"Ilahi NE, Bhatti A. Impact of HPV E5 on viral life cycle via EGFR signaling. Microb Pathog. 2020;139:103923.","journal-title":"Microb Pathog"},{"issue":"7\u20138","key":"6470_CR105","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00018-005-5561-x","volume":"63","author":"SH Kim","year":"2006","unstructured":"Kim SH, Juhnn YS, Kang S, Park SW, Sung MW, Bang YJ, et al. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK\/ ERK1,2 and PI3K\/Akt. Cell Mol Life Sci. 2006;63(7\u20138):930\u20138.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"6470_CR106","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","volume":"39","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wang T, Wu D, Min Z, Tan J, Yu B. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. J Exp Clin Cancer Res. 2020;39(1):203.","journal-title":"J Exp Clin Cancer Res"},{"key":"6470_CR107","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1476-4598-10-39","volume":"10","author":"S Mahata","year":"2011","unstructured":"Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer. 2011;10:39.","journal-title":"Mol Cancer"},{"issue":"8","key":"6470_CR108","doi-asserted-by":"publisher","first-page":"166817","DOI":"10.1016\/j.bbadis.2023.166817","volume":"1869","author":"K Thakur","year":"2023","unstructured":"Thakur K, Janjua D, Aggarwal N, Chhokar A, Yadav J, Tripathi T, et al. Physical interaction between STAT3 and AP1 in cervical carcinogenesis: implications in HPV transcription control. Biochim Biophys Acta Mol Basis Dis. 2023;1869(8):166817.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1\u20132","key":"6470_CR109","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.virusres.2006.02.005","volume":"120","author":"GH Ashrafi","year":"2006","unstructured":"Ashrafi GH, Brown DR, Fife KH, Campo MS. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res. 2006;120(1\u20132):208\u201311.","journal-title":"Virus Res"},{"issue":"9","key":"6470_CR110","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.3390\/ijms20092188","volume":"20","author":"F Bossler","year":"2019","unstructured":"Bossler F, Hoppe-Seyler K, Hoppe-Seyler F. PI3K\/AKT\/mTOR signaling regulates the virus\/host cell crosstalk in HPV-positive cervical cancer cells. Int J Mol Sci. 2019;20(9):2188.","journal-title":"Int J Mol Sci"},{"key":"6470_CR111","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wu J, Ling MT, Zhao L, Zhao KN. The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer. 2015;14:87.","journal-title":"Mol Cancer"},{"key":"6470_CR112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13027-020-00295-7","volume":"15","author":"S Tavakolian","year":"2020","unstructured":"Tavakolian S, Goudarzi H, Faghihloo E. Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers. Infect Agent Cancer. 2020;15:27.","journal-title":"Infect Agent Cancer"},{"issue":"18","key":"6470_CR113","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/onc.2014.169","volume":"34","author":"S Kagawa","year":"2015","unstructured":"Kagawa S, Natsuizaka M, Whelan KA, Facompre N, Naganuma S, Ohashi S, et al. Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities. Oncogene. 2015;34(18):2347\u201359.","journal-title":"Oncogene"},{"issue":"12","key":"6470_CR114","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1128\/JVI.77.12.7106-7112.2003","volume":"77","author":"P Nair","year":"2003","unstructured":"Nair P, Somasundaram K, Krishna S. Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB\/Akt-dependent pathway. J Virol. 2003;77(12):7106\u201312.","journal-title":"J Virol"},{"issue":"4","key":"6470_CR115","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234\u201348.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"6470_CR116","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4103\/ijc.IJC_251_21","volume":"60","author":"F Rahmani","year":"2023","unstructured":"Rahmani F, Hashemian P, Tabrizi AT, Ghorbani Z, Ziaeemehr A, Alijannejad S, et al. Regulatory role of miRNAs on Wnt\/\u03b2-catenin signaling in tumorigenesis of glioblastoma. Indian J Cancer. 2023;60(3):295\u2013302.","journal-title":"Indian J Cancer"},{"key":"6470_CR117","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11744","author":"GX Zhu","year":"2021","unstructured":"Zhu GX, Gao D, Shao ZZ, Chen L, Ding WJ, Yu QF. Wnt\/\u03b2-catenin signaling: causes and treatment targets of drug resistance in colorectal cancer (Review). Mol Med Rep. 2021. https:\/\/doi.org\/10.3892\/mmr.2020.11744.","journal-title":"Mol Med Rep"},{"key":"6470_CR118","doi-asserted-by":"publisher","first-page":"102041","DOI":"10.1016\/j.tice.2023.102041","volume":"82","author":"S Chakraborti","year":"2023","unstructured":"Chakraborti S, Karmakar A, Guha R, Ngan C, Kumar Das R, Whitaker N. Induction of epithelial to mesenchymal transition in HPV16 E6\/E7 oncogene transfected C33A cell line. Tissue Cell. 2023;82:102041.","journal-title":"Tissue Cell"},{"issue":"8","key":"6470_CR119","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.3390\/v7082842","volume":"7","author":"JO Bello","year":"2015","unstructured":"Bello JO, Nieva LO, Paredes AC, Gonzalez AM, Zavaleta LR, Lizano M. Regulation of the Wnt\/\u03b2-catenin signaling pathway by human papillomavirus E6 and E7 oncoproteins. Viruses. 2015;7(8):4734\u201355.","journal-title":"Viruses"},{"issue":"1","key":"6470_CR120","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13046-020-01745-1","volume":"39","author":"JJ Qiu","year":"2020","unstructured":"Qiu JJ, Sun SG, Tang XY, Lin YY, Hua KQ. Extracellular vesicular Wnt7b mediates HPV E6-induced cervical cancer angiogenesis by activating the \u03b2-catenin signaling pathway. J Exp Clin Cancer Res. 2020;39(1):260.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"6470_CR121","doi-asserted-by":"publisher","first-page":"e0187521","DOI":"10.1128\/jvi.01875-21","volume":"96","author":"J Poirson","year":"2022","unstructured":"Poirson J, Suarez IP, Straub ML, Cousido-Siah A, Peixoto P, Hervouet E, et al. High-risk mucosal human papillomavirus 16 (HPV16) E6 protein and cutaneous HPV5 and HPV8 E6 proteins employ distinct strategies to interfere with interferon regulatory factor 3-mediated beta interferon expression. J Virol. 2022;96(10):e0187521.","journal-title":"J Virol"},{"issue":"2","key":"6470_CR122","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/cancers13020353","volume":"13","author":"P Matarrese","year":"2021","unstructured":"Matarrese P, Vona R, Ascione B, Paggi MG, Mileo AM. Physical interaction between HPV16E7 and the actin-binding protein gelsolin regulates epithelial-mesenchymal transition via HIPPO-YAP axis. Cancers (Basel). 2021;13(2):353.","journal-title":"Cancers (Basel)"},{"issue":"16","key":"6470_CR123","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1158\/1078-0432.CCR-17-3775","volume":"24","author":"K Srivastava","year":"2018","unstructured":"Srivastava K, Pickard A, Craig SG, Quinn GP, Lambe SM, James JA, et al. \u0394Np63\u03b3\/SRC\/Slug signaling axis promotes epithelial-to-mesenchymal transition in squamous cancers. Clin Cancer Res. 2018;24(16):3917\u201327.","journal-title":"Clin Cancer Res"},{"key":"6470_CR124","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014195118","author":"H Liu","year":"2021","unstructured":"Liu H, Xu J, Yang Y, Wang X, Wu E, Majerciak V, et al. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2014195118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6470_CR125","doi-asserted-by":"publisher","first-page":"RP102681","DOI":"10.7554\/eLife.102681.1","volume":"13","author":"H Liu","year":"2024","unstructured":"Liu H, Yu L, Majerciak V, Meyer T, Yi M, Johnson PF, Cam M, Lowy DR, Zheng Z-M. The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling and phosphorylation of Akt and Erk in HPV16-infected cervical cancer. eLife. 2024;13:RP102681. https:\/\/doi.org\/10.7554\/eLife.102681.1.","journal-title":"eLife"},{"issue":"12","key":"6470_CR126","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1128\/JVI.00411-16","volume":"90","author":"SW Strickland","year":"2016","unstructured":"Strickland SW, Vande PS. The human papillomavirus 16 E7 oncoprotein attenuates AKT signaling to promote internal ribosome entry site-dependent translation and expression of c-MYC. J Virol. 2016;90(12):5611\u201321.","journal-title":"J Virol"},{"issue":"4","key":"6470_CR127","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/JVI.01812-19","volume":"94","author":"I Lo Cigno","year":"2020","unstructured":"Lo Cigno I, Calati F, Borgogna C, Zevini A, Albertini S, Martuscelli L, et al. Human papillomavirus E7 oncoprotein subverts host innate immunity via SUV39H1-mediated epigenetic silencing of immune sensor genes. J Virol. 2020;94(4):13.","journal-title":"J Virol"},{"key":"6470_CR128","doi-asserted-by":"publisher","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","volume":"30","author":"AB Moscicki","year":"2012","unstructured":"Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, et al. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 2012;30:F24-33.","journal-title":"Vaccine"},{"issue":"13","key":"6470_CR129","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.ejca.2015.06.001","volume":"51","author":"B Serrano","year":"2015","unstructured":"Serrano B, de Sanjos\u00e9 S, Tous S, Quiros B, Mu\u00f1oz N, Bosch X, et al. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer. 2015;51(13):1732\u201341.","journal-title":"Eur J Cancer"},{"issue":"Suppl 5","key":"6470_CR130","doi-asserted-by":"publisher","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","volume":"30","author":"ML Gillison","year":"2012","unstructured":"Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 2012;30(Suppl 5):F34-54.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"6470_CR131","doi-asserted-by":"publisher","first-page":"A46","DOI":"10.1016\/j.vaccine.2008.10.085","volume":"27","author":"P Bonanni","year":"2009","unstructured":"Bonanni P, Boccalini S, Bechini A. Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence. Vaccine. 2009;27(Suppl 1):A46-53.","journal-title":"Vaccine"},{"issue":"4","key":"6470_CR132","doi-asserted-by":"publisher","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","volume":"17","author":"KA Szymonowicz","year":"2020","unstructured":"Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer Biol Med. 2020;17(4):864\u201378.","journal-title":"Cancer Biol Med"},{"key":"6470_CR133","unstructured":"HPV and Oropharyngeal Cancer|CDC. https:\/\/www.cdc.gov\/cancer\/hpv\/basic_info\/hpv_oropharyngeal.htm. Accessed 14 Apr 2025."},{"issue":"3","key":"6470_CR134","doi-asserted-by":"publisher","first-page":"e1004113","DOI":"10.1371\/journal.pcbi.1004113","volume":"11","author":"MD Ryser","year":"2015","unstructured":"Ryser MD, Myers ER, Durrett R. HPV clearance and the neglected role of stochasticity. PLoS Comput Biol. 2015;11(3):e1004113.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"6470_CR135","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s44197-023-00172-7","volume":"14","author":"M Wang","year":"2024","unstructured":"Wang M, Huang K, Wong MCS, Huang J, Jin Y, Zheng ZJ. Global cervical cancer incidence by histological subtype and implications for screening methods. J Epidemiol Glob Health. 2024;14(1):94\u2013101.","journal-title":"J Epidemiol Glob Health"},{"issue":"7","key":"6470_CR136","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.3390\/curroncol29070372","volume":"29","author":"AD Campos-Parra","year":"2022","unstructured":"Campos-Parra AD, P\u00e9rez-Quintanilla M, Mart\u00ednez-Gutierrez AD, P\u00e9rez-Montiel D, Coronel-Mart\u00ednez J, Millan-Catalan O, et al. Molecular differences between squamous cell carcinoma and adenocarcinoma cervical cancer subtypes: potential prognostic biomarkers. Curr Oncol. 2022;29(7):4689\u2013702.","journal-title":"Curr Oncol"},{"issue":"13","key":"6470_CR137","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/cncr.30667","volume":"123","author":"W Small Jr","year":"2017","unstructured":"Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404\u201312.","journal-title":"Cancer"},{"issue":"4","key":"6470_CR138","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/path.2192","volume":"212","author":"M Pett","year":"2007","unstructured":"Pett M, Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol. 2007;212(4):356\u201367.","journal-title":"J Pathol"},{"issue":"2","key":"6470_CR139","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1158\/0008-5472.CAN-08-2478","volume":"69","author":"SM Wilting","year":"2009","unstructured":"Wilting SM, Steenbergen RD, Tijssen M, van Wieringen WN, Helmerhorst TJ, van Kemenade FJ, et al. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas. Cancer Res. 2009;69(2):647\u201355.","journal-title":"Cancer Res"},{"key":"6470_CR140","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.trsl.2022.09.004","volume":"253","author":"M Liu","year":"2023","unstructured":"Liu M, Han Z, Zhi Y, Ruan Y, Cao G, Wang G, et al. Long-read sequencing reveals oncogenic mechanism of HPV-human fusion transcripts in cervical cancer. Transl Res. 2023;253:80\u201394.","journal-title":"Transl Res"},{"issue":"7","key":"6470_CR141","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/jcp.50.7.600","volume":"50","author":"L Pirami","year":"1997","unstructured":"Pirami L, Giach\u00e8 V, Becciolini A. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol. 1997;50(7):600\u20134.","journal-title":"J Clin Pathol"},{"issue":"2","key":"6470_CR142","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/jvi.65.2.606-612.1991","volume":"65","author":"AP Cullen","year":"1991","unstructured":"Cullen AP, Reid R, Campion M, L\u00f6rincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 1991;65(2):606\u201312.","journal-title":"J Virol"},{"issue":"1","key":"6470_CR143","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/cancers15010263","volume":"15","author":"R Polten","year":"2022","unstructured":"Polten R, Kutle I, Hachenberg J, Klapdor R, Morgan M, Schambach A. Towards novel gene and cell therapy approaches for cervical cancer. Cancers (Basel). 2022;15(1):263.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"6470_CR144","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s13337-022-00768-w","volume":"33","author":"PS Ojha","year":"2022","unstructured":"Ojha PS, Maste MM, Tubachi S, Patil VS. Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies. Virusdisease. 2022;33(2):132\u201354.","journal-title":"Virusdisease"},{"key":"6470_CR145","unstructured":"U.S. Cancer Statistics Working Group. U.S. cancer statistics data visualizations tool. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. 2022. https:\/\/www.cdc.gov\/cancer\/dataviz."},{"issue":"6","key":"6470_CR146","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/oncolo\/oyae071","volume":"29","author":"AA McBride","year":"2024","unstructured":"McBride AA. Human malignancies associated with persistent HPV infection. Oncologist. 2024;29(6):457\u201364.","journal-title":"Oncologist"},{"issue":"5","key":"6470_CR147","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19(5):306\u201327.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"6470_CR148","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.hoc.2021.05.004","volume":"35","author":"EM Rettig","year":"2021","unstructured":"Rettig EM, Sethi RKV. Cancer of the oropharynx and the association with human papillomavirus. Hematol Oncol Clin North Am. 2021;35(5):913\u201331.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"6470_CR149","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s12250-021-00413-8","volume":"36","author":"H Dong","year":"2021","unstructured":"Dong H, Shu X, Xu Q, Zhu C, Kaufmann AM, Zheng ZM, et al. Current status of human papillomavirus-related head and neck cancer: from viral genome to patient care. Virol Sin. 2021;36(6):1284\u2013302.","journal-title":"Virol Sin"},{"key":"6470_CR150","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.biopha.2018.06.149","volume":"106","author":"RP Araldi","year":"2018","unstructured":"Araldi RP, Sant\u2019Ana TA, M\u00f3dolo DG, de Melo TC, Spadacci-Morena DD, de Cassia SR, et al. The human papillomavirus (HPV)-related cancer biology: An overview. Biomed Pharmacother. 2018;106:1537\u201356.","journal-title":"Biomed Pharmacother"},{"issue":"7\u20138","key":"6470_CR151","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.gyobfe.2011.05.010","volume":"39","author":"J Monsonego","year":"2011","unstructured":"Monsonego J. EUROGIN 2010: roadmap on cervical cancer prevention. Gynecol Obstet Fertil. 2011;39(7\u20138):462\u20137.","journal-title":"Gynecol Obstet Fertil"},{"issue":"1","key":"6470_CR152","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.soc.2016.07.010","volume":"26","author":"CJ Wang","year":"2017","unstructured":"Wang CJ, Sparano J, Palefsky JM. Human immunodeficiency virus\/AIDS, human papillomavirus, and anal cancer. Surg Oncol Clin N Am. 2017;26(1):17\u201331.","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"6470_CR153","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pathol.2021.07.003","volume":"54","author":"N Assarzadegan","year":"2022","unstructured":"Assarzadegan N, Brooks E, Voltaggio L. HPV-driven anal neoplasia: review and recent developments. Pathology. 2022;54(2):184\u201394.","journal-title":"Pathology"},{"issue":"5","key":"6470_CR154","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.currproblcancer.2018.11.001","volume":"42","author":"M Morton","year":"2018","unstructured":"Morton M, Melnitchouk N, Bleday R. Squamous cell carcinoma of the anal canal. Curr Probl Cancer. 2018;42(5):486\u201392.","journal-title":"Curr Probl Cancer"},{"issue":"24","key":"6470_CR155","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","volume":"386","author":"JM Palefsky","year":"2022","unstructured":"Palefsky JM, Lee JY, Jay N, Goldstone SE, Darragh TM, Dunlevy HA, et al. Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer. N Engl J Med. 2022;386(24):2273\u201382.","journal-title":"N Engl J Med"},{"issue":"17","key":"6470_CR156","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011;365(17):1576\u201385.","journal-title":"N Engl J Med"},{"issue":"4","key":"6470_CR157","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.semradonc.2021.02.011","volume":"31","author":"KR Dahlstrom","year":"2021","unstructured":"Dahlstrom KR, Day AT, Sturgis EM. Prevention and screening of HPV malignancies. Semin Radiat Oncol. 2021;31(4):297\u2013308.","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"6470_CR158","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1071\/SH15170","volume":"13","author":"RJ Hillman","year":"2016","unstructured":"Hillman RJ, Gunathilake MP, Jin F, Tong W, Field A, Carr A. Ability to detect high-grade squamous anal intraepithelial lesions at high resolution anoscopy improves over time. Sex Health. 2016;13(2):177\u201381.","journal-title":"Sex Health"},{"issue":"7","key":"6470_CR159","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/cncy.22018","volume":"126","author":"MA Clarke","year":"2018","unstructured":"Clarke MA, Wentzensen N. Strategies for screening and early detection of anal cancers: a narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers. Cancer Cytopathol. 2018;126(7):447\u201360.","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"6470_CR160","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/vaccines11061084","volume":"11","author":"A Bechini","year":"2023","unstructured":"Bechini A, Moscadelli A, Velpini B, Bonito B, Orlando P, Putignano P, et al. Efficacy of HPV vaccination regarding vulvar and vaginal recurrences in previously treated women: the need for further evidence. Vaccines (Basel). 2023;11(6):1084.","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"6470_CR161","first-page":"613","volume":"45","author":"EA Joura","year":"2000","unstructured":"Joura EA, L\u00f6sch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med. 2000;45(8):613\u20135.","journal-title":"J Reprod Med"},{"issue":"3","key":"6470_CR162","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"6470_CR163","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664\u201370. https:\/\/doi.org\/10.1002\/ijc.30716.","journal-title":"Int J Cancer"},{"issue":"3","key":"6470_CR164","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ygyno.2007.11.011","volume":"108","author":"AM Stroup","year":"2008","unstructured":"Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol. 2008;108(3):577\u201383.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6470_CR165","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/jdv.19393","volume":"38","author":"MJ Guimaraes","year":"2024","unstructured":"Guimaraes MJ, Macieira R, Azevedo F, Lisboa C. Association between HPV infection and penile cancer and penile intraepithelial neoplasia: a retrospective observational study. J Eur Acad Dermatol Venereol. 2024;38(1):186\u201390.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"6470_CR166","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/iju.13871","volume":"26","author":"RJ Hoekstra","year":"2019","unstructured":"Hoekstra RJ, Trip EJ, Ten Kate FJ, Horenblas S, Lock MT. Penile intraepithelial neoplasia: nomenclature, incidence and progression to malignancy in the Netherlands. Int J Urol. 2019;26(3):353\u20137.","journal-title":"Int J Urol"},{"issue":"1","key":"6470_CR167","first-page":"91","volume":"20","author":"L Iorga","year":"2020","unstructured":"Iorga L, Dragos Marcu R, Cristina Diaconu C, Maria Alexandra Stanescu A, Pantea Stoian A, Liviu Dorel Mischianu D, et al. Penile carcinoma and HPV infection (Review). Exp Ther Med. 2020;20(1):91\u20136.","journal-title":"Exp Ther Med"},{"key":"6470_CR168","doi-asserted-by":"publisher","first-page":"175883592211272","DOI":"10.1177\/17588359221127254","volume":"14","author":"J Chadha","year":"2022","unstructured":"Chadha J, Chahoud J, Spiess PE. An update on treatment of penile cancer. Ther Adv Med Oncol. 2022;14:17588359221127254.","journal-title":"Ther Adv Med Oncol"},{"key":"6470_CR169","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.humpath.2022.06.010","volume":"133","author":"AP Sali","year":"2023","unstructured":"Sali AP, Prakash G, Murthy V, Joshi A, Shah A, Desai SB, et al. Updates in staging of penile cancer: the evolution, nuances, and issues. Hum Pathol. 2023;133:76\u201386.","journal-title":"Hum Pathol"},{"issue":"1","key":"6470_CR170","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jasc.2023.09.007","volume":"13","author":"AA Swanson","year":"2024","unstructured":"Swanson AA, Pantanowitz L. The evolution of cervical cancer screening. J Am Soc Cytopathol. 2024;13(1):10\u20135.","journal-title":"J Am Soc Cytopathol"},{"key":"6470_CR171","unstructured":"Lyon F. IARC. Cervix cancer screening. Cancer IAfRo. 2005."},{"key":"6470_CR172","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ypmed.2018.12.021","volume":"119","author":"NJ Polman","year":"2019","unstructured":"Polman NJ, Snijders PJF, Kenter GG, Berkhof J, Meijer C. HPV-based cervical screening: rationale, expectations and future perspectives of the new Dutch screening programme. Prev Med. 2019;119:108\u201317.","journal-title":"Prev Med"},{"issue":"4","key":"6470_CR173","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.arcmed.2015.05.013","volume":"46","author":"E Yunes-D\u00edaz","year":"2015","unstructured":"Yunes-D\u00edaz E, Ruiz PA, Lazcano-Ponce E. Assessment of the validity and reproducibility of the pap smear in Mexico: necessity of a paradigm shift. Arch Med Res. 2015;46(4):310\u20136.","journal-title":"Arch Med Res"},{"issue":"9585","key":"6470_CR174","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0140-6736(07)61195-7","volume":"370","author":"R Sankaranarayanan","year":"2007","unstructured":"Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370(9585):398\u2013406.","journal-title":"Lancet"},{"issue":"2","key":"6470_CR175","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/ijmr.IJMR_857_20","volume":"154","author":"S Rajaram","year":"2021","unstructured":"Rajaram S, Gupta B. Screening for cervical cancer: choices & dilemmas. Indian J Med Res. 2021;154(2):210\u201320.","journal-title":"Indian J Med Res"},{"issue":"1","key":"6470_CR176","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12905-022-01592-6","volume":"22","author":"A Bai","year":"2022","unstructured":"Bai A, Wang J, Li Q, Seery S, Xue P, Jiang Y. Assessing colposcopic accuracy for high-grade squamous intraepithelial lesion detection: a retrospective, cohort study. BMC Womens Health. 2022;22(1):9.","journal-title":"BMC Womens Health"},{"issue":"14","key":"6470_CR177","doi-asserted-by":"publisher","first-page":"761","DOI":"10.21037\/atm-22-1732","volume":"10","author":"T Li","year":"2022","unstructured":"Li T, Lai Y, Yuan J. The diagnostic accuracy of TCT + HPV-DNA for cervical cancer: systematic review and meta-analysis. Ann Transl Med. 2022;10(14):761.","journal-title":"Ann Transl Med"},{"issue":"2","key":"6470_CR178","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3802\/jgo.2015.26.2.156","volume":"26","author":"DH Suh","year":"2015","unstructured":"Suh DH, Lee KH, Kim K, Kang S, Kim JW. Major clinical research advances in gynecologic cancer in 2014. J Gynecol Oncol. 2015;26(2):156\u201367.","journal-title":"J Gynecol Oncol"},{"key":"6470_CR179","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.acc.2017.01.004","volume":"81","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Wang Y, Hirschhorn J, Welsh KJ, Zhao Z, Davis MR, et al. Human papillomavirus and its testing assays, cervical cancer screening, and vaccination. Adv Clin Chem. 2017;81:135\u201392.","journal-title":"Adv Clin Chem"},{"issue":"3","key":"6470_CR180","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1055-9965.EPI-20-1003","volume":"30","author":"LA Liang","year":"2021","unstructured":"Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, et al. Cervical cancer screening: comparison of conventional pap smear test, liquid-based cytology, and human papillomavirus testing as stand-alone or cotesting strategies. Cancer Epidemiol Biomarkers Prev. 2021;30(3):474\u201384.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"6470_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/LGT.0000000000000494","volume":"24","author":"JH Bonde","year":"2020","unstructured":"Bonde JH, Sandri MT, Gary DS, Andrews JC. Clinical utility of human papillomavirus genotyping in cervical cancer screening: a systematic review. J Low Genit Tract Dis. 2020;24(1):1\u201313.","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"6470_CR182","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ajcp\/aqy169","volume":"151","author":"MH Stoler","year":"2019","unstructured":"Stoler MH, Wright TC, Parvu V, Yanson K, Eckert K, Kodsi S, et al. HPV testing with 16, 18, and 45 genotyping stratifies cancer risk for women with normal cytology. Am J Clin Pathol. 2019;151(4):433\u201342.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"6470_CR183","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12985-018-0957-z","volume":"15","author":"MT Bruno","year":"2018","unstructured":"Bruno MT, Ferrara M, Fava V, Rapisarda A, Coco A. HPV genotype determination and E6\/E7 mRNA detection for management of HPV positive women. Virol J. 2018;15(1):52.","journal-title":"Virol J"},{"issue":"2","key":"6470_CR184","doi-asserted-by":"publisher","first-page":"e29409","DOI":"10.1002\/jmv.29409","volume":"96","author":"M Bartosik","year":"2024","unstructured":"Bartosik M, Moranova L, Izadi N, Strmiskova J, Sebuyoya R, Holcakova J, et al. Advanced technologies towards improved HPV diagnostics. J Med Virol. 2024;96(2):e29409.","journal-title":"J Med Virol"},{"key":"6470_CR185","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcv.2016.01.002","volume":"75","author":"DM Livingstone","year":"2016","unstructured":"Livingstone DM, Rohatensky M, Mintchev P, Nakoneshny SC, Demetrick DJ, van Marle G, et al. Loop mediated isothermal amplification (LAMP) for the detection and subtyping of human papillomaviruses (HPV) in oropharyngeal squamous cell carcinoma (OPSCC). J Clin Virol. 2016;75:37\u201341.","journal-title":"J Clin Virol"},{"issue":"1\u20132","key":"6470_CR186","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jviromet.2011.08.007","volume":"178","author":"C Saetiew","year":"2011","unstructured":"Saetiew C, Limpaiboon T, Jearanaikoon P, Daduang S, Pientong C, Kerdsin A, et al. Rapid detection of the most common high-risk human papillomaviruses by loop-mediated isothermal amplification. J Virol Methods. 2011;178(1\u20132):22\u201330.","journal-title":"J Virol Methods"},{"key":"6470_CR187","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13027-020-00328-1","volume":"15","author":"W Zhang","year":"2020","unstructured":"Zhang W, Du H, Huang X, Wang C, Duan X, Liu Y, et al. Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening. Infect Agent Cancer. 2020;15:65.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"6470_CR188","doi-asserted-by":"publisher","first-page":"100411","DOI":"10.1016\/j.jsamd.2021.100411","volume":"7","author":"KY Avelino","year":"2022","unstructured":"Avelino KY, Oliveira LS, de Oliveira HP, Lucena-Silva N, Andrade CA, Oliveira MD. Impedimetric sensing platform for human papillomavirus and p53 tumor suppressor gene in cervical samples. J Sci Adv Mater Devices. 2022;7(1):100411.","journal-title":"J Sci Adv Mater Devices"},{"key":"6470_CR189","doi-asserted-by":"publisher","first-page":"122118","DOI":"10.1016\/j.talanta.2021.122118","volume":"226","author":"K Avelino","year":"2021","unstructured":"Avelino K, Oliveira LS, Lucena-Silva N, Andrade CAS, Oliveira MDL. Flexible sensor based on conducting polymer and gold nanoparticles for electrochemical screening of HPV families in cervical specimens. Talanta. 2021;226:122118.","journal-title":"Talanta"},{"key":"6470_CR190","doi-asserted-by":"publisher","first-page":"132296","DOI":"10.1016\/j.snb.2022.132296","volume":"369","author":"U Ganbaatar","year":"2022","unstructured":"Ganbaatar U, Liu C. NEXT CRISPR: An enhanced CRISPR-based nucleic acid biosensing platform using extended crRNA. Sens Actuators, B Chem. 2022;369:132296.","journal-title":"Sens Actuators, B Chem"},{"issue":"1","key":"6470_CR191","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jmoldx.2020.10.004","volume":"23","author":"J Gao","year":"2021","unstructured":"Gao J, Wu L, Yang D, Gong W, Wang J. A one-pot CRISPR\/Cas9-typing PCR for DNA detection and genotyping. J Mol Diagn. 2021;23(1):46\u201360.","journal-title":"J Mol Diagn"},{"issue":"1","key":"6470_CR192","doi-asserted-by":"publisher","first-page":"12800","DOI":"10.1038\/s41598-021-92329-2","volume":"11","author":"J Gong","year":"2021","unstructured":"Gong J, Zhang G, Wang W, Liang L, Li Q, Liu M, et al. A simple and rapid diagnostic method for 13 types of high-risk human papillomavirus (HR-HPV) detection using CRISPR-Cas12a technology. Sci Rep. 2021;11(1):12800.","journal-title":"Sci Rep"},{"issue":"6","key":"6470_CR193","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1021\/acs.analchem.2c04713","volume":"95","author":"H Zhou","year":"2023","unstructured":"Zhou H, Xu Z, He L, Wang Z, Zhang T, Hu T, et al. Coupling CRISPR\/Cas12a and recombinase polymerase amplification on a stand-alone microfluidics platform for fast and parallel nucleic acid detection. Anal Chem. 2023;95(6):3379\u201389.","journal-title":"Anal Chem"},{"key":"6470_CR194","doi-asserted-by":"publisher","first-page":"113498","DOI":"10.1016\/j.bios.2021.113498","volume":"192","author":"Z Li","year":"2021","unstructured":"Li Z, Ding X, Yin K, Xu Z, Cooper K, Liu C. Electric field-enhanced electrochemical CRISPR biosensor for DNA detection. Biosens Bioelectron. 2021;192:113498.","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"6470_CR195","doi-asserted-by":"publisher","first-page":"14126","DOI":"10.1038\/s41598-018-32329-x","volume":"8","author":"Q Wang","year":"2018","unstructured":"Wang Q, Zhang B, Xu X, Long F, Wang J. CRISPR-typing PCR (ctPCR), a new Cas9-based DNA detection method. Sci Rep. 2018;8(1):14126.","journal-title":"Sci Rep"},{"issue":"6","key":"6470_CR196","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/crispr.2020.0041","volume":"3","author":"X Xu","year":"2020","unstructured":"Xu X, Luo T, Gao J, Lin N, Li W, Xia X, et al. CRISPR-assisted DNA detection: a novel dCas9-based DNA detection technique. Crispr j. 2020;3(6):487\u2013502.","journal-title":"Crispr j"},{"issue":"1","key":"6470_CR197","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1038\/s41467-022-34086-y","volume":"13","author":"Z Xu","year":"2022","unstructured":"Xu Z, Chen D, Li T, Yan J, Zhu J, He T, et al. Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification. Nat Commun. 2022;13(1):6480.","journal-title":"Nat Commun"},{"issue":"2","key":"6470_CR198","first-page":"966","volume":"95","author":"Y Xue","year":"2023","unstructured":"Xue Y, Luo X, Xu W, Wang K, Wu M, Chen L, et al. PddCas: a polydisperse droplet digital CRISPR\/Cas-based assay for the rapid and ultrasensitive amplification-free detection of viral DNA\/RNA. Anal Chem. 2023;95(2):966\u201375.","journal-title":"Anal Chem"},{"issue":"6","key":"6470_CR199","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/acscentsci.1c00186","volume":"7","author":"M Zamani","year":"2021","unstructured":"Zamani M, Robson JM, Fan A, Bono MS Jr, Furst AL, Klapperich CM. Electrochemical strategy for low-cost viral detection. ACS Cent Sci. 2021;7(6):963\u201372.","journal-title":"ACS Cent Sci"},{"issue":"6","key":"6470_CR200","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1021\/acs.analchem.2c05320","volume":"95","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Chen D, Xu Z, Li T, Zhu J, Hu R, et al. Integrating CRISPR-Cas12a into a Microfluidic dual-droplet device enables simultaneous detection of HPV16 and HPV18. Anal Chem. 2023;95(6):3476\u201385.","journal-title":"Anal Chem"},{"key":"6470_CR201","doi-asserted-by":"publisher","first-page":"115323","DOI":"10.1016\/j.bios.2023.115323","volume":"232","author":"J Han","year":"2023","unstructured":"Han J, Shin J, Lee ES, Cha BS, Kim S, Jang Y, et al. Cas12a\/blocker DNA-based multiplex nucleic acid detection system for diagnosis of high-risk human papillomavirus infection. Biosens Bioelectron. 2023;232:115323.","journal-title":"Biosens Bioelectron"},{"issue":"12","key":"6470_CR202","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.tranon.2019.08.011","volume":"12","author":"JH Tsou","year":"2019","unstructured":"Tsou JH, Leng Q, Jiang F. A CRISPR test for detection of circulating nuclei acids. Transl Oncol. 2019;12(12):1566\u201373.","journal-title":"Transl Oncol"},{"issue":"5","key":"6470_CR203","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","volume":"70","author":"ETH Fontham","year":"2020","unstructured":"Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321\u201346.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"6470_CR204","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/annonc\/mdp471","volume":"21","author":"M Arbyn","year":"2010","unstructured":"Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. European guidelines for quality assurance in cervical cancer screening. Second edition\u2013summary document. Ann Oncol. 2010;21(3):448\u201358.","journal-title":"Ann Oncol"},{"issue":"11","key":"6470_CR205","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s11606-016-3772-5","volume":"31","author":"XW Jin","year":"2016","unstructured":"Jin XW, Lipold L, Foucher J, Sikon A, Brainard J, Belinson J, et al. Cost-effectiveness of primary HPV testing, cytology and co-testing as cervical cancer screening for women above age 30 years. J Gen Intern Med. 2016;31(11):1338\u201344.","journal-title":"J Gen Intern Med"},{"issue":"11","key":"6470_CR206","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/ijc.34199","volume":"151","author":"MA Clarke","year":"2022","unstructured":"Clarke MA, Deshmukh AA, Suk R, Roberts J, Gilson R, Jay N, et al. A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups. Int J Cancer. 2022;151(11):1889\u2013901.","journal-title":"Int J Cancer"},{"key":"6470_CR207","unstructured":"Treatment CSTS. Health Professional Version\u2014National Cancer Institute. USA: National Cancer Institute. 2018."},{"issue":"5","key":"6470_CR208","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/v16050680","volume":"16","author":"JE Jensen","year":"2024","unstructured":"Jensen JE, Becker GL, Jackson JB, Rysavy MB. Human papillomavirus and associated cancers: a review. Viruses. 2024;16(5):680. https:\/\/doi.org\/10.3390\/v16050680.","journal-title":"Viruses"},{"issue":"6","key":"6470_CR209","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0038-1668102","volume":"31","author":"KM Lyons","year":"2018","unstructured":"Lyons KM, Butler SL. Anal intraepithelial neoplasia from a pathologists point of view. Clin Colon Rectal Surg. 2018;31(6):328\u201335.","journal-title":"Clin Colon Rectal Surg"},{"key":"6470_CR210","doi-asserted-by":"publisher","first-page":"106293","DOI":"10.1016\/j.ypmed.2020.106293","volume":"144","author":"JML Brotherton","year":"2021","unstructured":"Brotherton JML, Wheeler C, Clifford GM, Elfstr\u00f6m M, Saville M, Kaldor J, et al. Surveillance systems for monitoring cervical cancer elimination efforts: focus on HPV infection, cervical dysplasia, cervical screening and treatment. Prev Med. 2021;144:106293.","journal-title":"Prev Med"},{"key":"6470_CR211","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. https:\/\/www.who.int\/publications\/i\/item\/9789240030824. Accessed 14 Apr 2025."},{"issue":"11","key":"6470_CR212","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/14737159.2020.1835472","volume":"20","author":"MA Molina","year":"2020","unstructured":"Molina MA, Carosi Diatricch L, Castany Quintana M, Melchers WJ, Andralojc KM. Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection. Expert Rev Mol Diagn. 2020;20(11):1099\u2013120.","journal-title":"Expert Rev Mol Diagn"},{"issue":"12","key":"6470_CR213","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1128\/JCM.01275-09","volume":"47","author":"P Cattani","year":"2009","unstructured":"Cattani P, Zannoni GF, Ricci C, D\u2019Onghia S, Trivellizzi IN, Di Franco A, et al. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol. 2009;47(12):3895\u2013901.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"6470_CR214","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ygyno.2010.09.013","volume":"120","author":"G Coquillard","year":"2011","unstructured":"Coquillard G, Palao B, Patterson BK. Quantification of intracellular HPV E6\/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol. 2011;120(1):89\u201393.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6470_CR215","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jviromet.2008.09.027","volume":"155","author":"H Keegan","year":"2009","unstructured":"Keegan H, Mc Inerney J, Pilkington L, Gr\u00f8nn P, Silva I, Karlsen F, et al. Comparison of HPV detection technologies: hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6\/E7 mRNA positive specimens. J Virol Methods. 2009;155(1):61\u20136.","journal-title":"J Virol Methods"},{"issue":"8","key":"6470_CR216","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1128\/JCM.00382-10","volume":"48","author":"S Ratnam","year":"2010","unstructured":"Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, Ghatage P, et al. Clinical performance of the PreTect HPV-Proofer E6\/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer. J Clin Microbiol. 2010;48(8):2779\u201385.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"6470_CR217","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jviromet.2010.07.011","volume":"169","author":"SW Sorbye","year":"2010","unstructured":"Sorbye SW, Fismen S, Gutteberg TJ, Mortensen ES. HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway. J Virol Methods. 2010;169(1):219\u201322.","journal-title":"J Virol Methods"},{"issue":"3","key":"6470_CR218","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1631\/jzus.B1600288","volume":"18","author":"YL Yao","year":"2017","unstructured":"Yao YL, Tian QF, Cheng B, Cheng YF, Ye J, Lu WG. Human papillomavirus (HPV) E6\/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women. J Zhejiang Univ Sci B. 2017;18(3):256\u201362.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1","key":"6470_CR219","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1186\/s12885-016-2885-x","volume":"16","author":"N Fontecha","year":"2016","unstructured":"Fontecha N, Basaras M, Hern\u00e1ez S, And\u00eda D, Cisterna R. Assessment of human papillomavirus E6\/E7 oncogene expression as cervical disease biomarker. BMC Cancer. 2016;16(1):852.","journal-title":"BMC Cancer"},{"issue":"1","key":"6470_CR220","doi-asserted-by":"publisher","first-page":"20047","DOI":"10.1038\/s41598-024-71112-z","volume":"14","author":"X Cai","year":"2024","unstructured":"Cai X, Huang W, Huang J, Zhu X, Wang L, Xia Z, et al. CAPZB mRNA is a novel biomarker for cervical high-grade squamous lesions. Sci Rep. 2024;14(1):20047.","journal-title":"Sci Rep"},{"key":"6470_CR221","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2023.06.011","volume":"205","author":"PS Ramesh","year":"2023","unstructured":"Ramesh PS, Bovilla VR, Swamy VH, Manoli NN, Dasegowda KB, Siddegowda SM, et al. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma. Free Radic Biol Med. 2023;205:234\u201343.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"6470_CR222","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.3390\/curroncol29120779","volume":"29","author":"J Soboci\u0144ska","year":"2022","unstructured":"Soboci\u0144ska J, Nowakowska J, Molenda S, Olechnowicz A, Guglas K, Koz\u0142owska-Mas\u0142o\u0144 J, et al. Zinc finger proteins in head and neck squamous cell carcinomas: ZNF540 may serve as a biomarker. Curr Oncol. 2022;29(12):9896\u2013915.","journal-title":"Curr Oncol"},{"issue":"10","key":"6470_CR223","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/biom12101458","volume":"12","author":"Q Wu","year":"2022","unstructured":"Wu Q, Shao T, Huang G, Zheng Z, Jiang Y, Zeng W, et al. FDCSP is an immune-associated prognostic biomarker in HPV-positive head and neck squamous carcinoma. Biomolecules. 2022;12(10):1458.","journal-title":"Biomolecules"},{"issue":"1","key":"6470_CR224","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5\u201318.","journal-title":"Nat Rev Cancer"},{"key":"6470_CR225","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fonc.2020.00150","volume":"10","author":"ML Tornesello","year":"2020","unstructured":"Tornesello ML, Faraonio R, Buonaguro L, Annunziata C, Starita N, Cerasuolo A, et al. The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer. Front Oncol. 2020;10:150.","journal-title":"Front Oncol"},{"key":"6470_CR226","doi-asserted-by":"publisher","first-page":"886613","DOI":"10.3389\/fgene.2022.886613","volume":"13","author":"R Castro-Oropeza","year":"2022","unstructured":"Castro-Oropeza R, Pi\u00f1a-S\u00e1nchez P. Epigenetic and transcriptomic regulation landscape in HPV+ cancers: biological and clinical implications. Front Genet. 2022;13:886613.","journal-title":"Front Genet"},{"key":"6470_CR227","doi-asserted-by":"publisher","first-page":"103192","DOI":"10.1016\/j.critrevonc.2020.103192","volume":"157","author":"ZS Razavi","year":"2021","unstructured":"Razavi ZS, Tajiknia V, Majidi S, Ghandali M, Mirzaei HR, Rahimian N, et al. Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles. Crit Rev Oncol Hematol. 2021;157:103192.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"6470_CR228","doi-asserted-by":"publisher","first-page":"e2557","DOI":"10.1371\/journal.pone.0002557","volume":"3","author":"X Wang","year":"2008","unstructured":"Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE. 2008;3(7):e2557.","journal-title":"PLoS ONE"},{"issue":"11\u201312","key":"6470_CR229","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbagrm.2011.05.005","volume":"1809","author":"ZM Zheng","year":"2011","unstructured":"Zheng ZM, Wang X. Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta. 2011;1809(11\u201312):668\u201377.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"6470_CR230","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.1401430111","volume":"111","author":"X Wang","year":"2014","unstructured":"Wang X, Wang HK, Li Y, Hafner M, Banerjee NS, Tang S, et al. microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A. 2014;111(11):4262\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6470_CR231","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/ijc.25800","volume":"129","author":"X Wang","year":"2011","unstructured":"Wang X, Meyers C, Guo M, Zheng ZM. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer. 2011;129(6):1362\u201372.","journal-title":"Int J Cancer"},{"issue":"1","key":"6470_CR232","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s12885-018-4590-4","volume":"18","author":"B Pardini","year":"2018","unstructured":"Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G, Naccarati A. MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer. 2018;18(1):696.","journal-title":"BMC Cancer"},{"issue":"10","key":"6470_CR233","doi-asserted-by":"publisher","first-page":"e0164701","DOI":"10.1371\/journal.pone.0164701","volume":"11","author":"D Gao","year":"2016","unstructured":"Gao D, Zhang Y, Zhu M, Liu S, Wang X. miRNA expression profiles of HPV-infected patients with cervical cancer in the uyghur population in China. PLoS ONE. 2016;11(10):e0164701.","journal-title":"PLoS ONE"},{"issue":"5","key":"6470_CR234","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.ajpath.2011.07.037","volume":"179","author":"F Wang","year":"2011","unstructured":"Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, et al. miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol. 2011;179(5):2580\u20138.","journal-title":"Am J Pathol"},{"issue":"12","key":"6470_CR235","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/1878-0261.12383","volume":"12","author":"SS Liu","year":"2018","unstructured":"Liu SS, Chan KKL, Chu DKH, Wei TN, Lau LSK, Ngu SF, et al. Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer. Mol Oncol. 2018;12(12):2009\u201322.","journal-title":"Mol Oncol"},{"issue":"10","key":"6470_CR236","doi-asserted-by":"publisher","first-page":"e0205077","DOI":"10.1371\/journal.pone.0205077","volume":"13","author":"R House","year":"2018","unstructured":"House R, Majumder M, Janakiraman H, Ogretmen B, Kato M, Erkul E, et al. Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer. PLoS ONE. 2018;13(10):e0205077.","journal-title":"PLoS ONE"},{"issue":"3","key":"6470_CR237","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/CBM-203149","volume":"33","author":"BG Weiss","year":"2022","unstructured":"Weiss BG, Anczykowski MZ, Ihler F, Bertlich M, Spiegel JL, Haubner F, et al. MicroRNA-182-5p and microRNA-205-5p as potential biomarkers for prognostic stratification of p16-positive oropharyngeal squamous cell carcinoma. Cancer Biomark. 2022;33(3):331\u201347.","journal-title":"Cancer Biomark"},{"key":"6470_CR238","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.04.021","volume":"82","author":"C Bersani","year":"2018","unstructured":"Bersani C, Mints M, Tertipis N, Haeggblom L, N\u00e4sman A, Romanitan M, et al. MicroRNA-155, -185 and -193b as biomarkers in human papillomavirus positive and negative tonsillar and base of tongue squamous cell carcinoma. Oral Oncol. 2018;82:8\u201316.","journal-title":"Oral Oncol"},{"key":"6470_CR239","doi-asserted-by":"publisher","first-page":"110209","DOI":"10.1016\/j.biopha.2020.110209","volume":"127","author":"J He","year":"2020","unstructured":"He J, Huang B, Zhang K, Liu M, Xu T. Long non-coding RNA in cervical cancer: from biology to therapeutic opportunity. Biomed Pharmacother. 2020;127:110209.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6470_CR240","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12967-021-02705-9","volume":"19","author":"Q Zhong","year":"2021","unstructured":"Zhong Q, Lu M, Yuan W, Cui Y, Ouyang H, Fan Y, et al. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data. J Transl Med. 2021;19(1):58.","journal-title":"J Transl Med"},{"issue":"12","key":"6470_CR241","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1111\/jcmm.13288","volume":"21","author":"IV Iancu","year":"2017","unstructured":"Iancu IV, Anton G, Botezatu A, Huica I, Nastase A, Socolov DG, et al. LINC01101 and LINC00277 expression levels as novel factors in HPV-induced cervical neoplasia. J Cell Mol Med. 2017;21(12):3787\u201394.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"6470_CR242","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/diagnostics10100762","volume":"10","author":"M Kopczy\u0144ska","year":"2020","unstructured":"Kopczy\u0144ska M, Kolenda T, Guglas K, Soboci\u0144ska J, Teresiak A, Bli\u017aniak R, et al. PRINS lncRNA is a new biomarker candidate for HPV infection and prognosis of head and neck squamous cell carcinomas. Diagnostics (Basel). 2020;10(10):762.","journal-title":"Diagnostics (Basel)"},{"issue":"25","key":"6470_CR243","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1021\/bi200642e","volume":"50","author":"J Li","year":"2011","unstructured":"Li J, Poi MJ, Tsai MD. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry. 2011;50(25):5566\u201382.","journal-title":"Biochemistry"},{"key":"6470_CR244","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.oraloncology.2016.01.002","volume":"54","author":"PP Sedghizadeh","year":"2016","unstructured":"Sedghizadeh PP, Billington WD, Paxton D, Ebeed R, Mahabady S, Clark GT, et al. Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis. Oral Oncol. 2016;54:15\u201327.","journal-title":"Oral Oncol"},{"issue":"3","key":"6470_CR245","doi-asserted-by":"publisher","first-page":"189106","DOI":"10.1016\/j.bbcan.2024.189106","volume":"1879","author":"P Garg","year":"2024","unstructured":"Garg P, Krishna M, Subbalakshmi AR, Ramisetty S, Mohanty A, Kulkarni P, et al. Emerging biomarkers and molecular targets for precision medicine in cervical cancer. Biochim Biophys Acta Rev Cancer. 2024;1879(3):189106.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"4","key":"6470_CR246","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/PAS.0b013e31802ca3f4","volume":"31","author":"SM Bean","year":"2007","unstructured":"Bean SM, Eltoum I, Horton DK, Whitlow L, Chhieng DC. Immunohistochemical expression of p16 and Ki-67 correlates with degree of anal intraepithelial neoplasia. Am J Surg Pathol. 2007;31(4):555\u201361.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"6470_CR247","doi-asserted-by":"publisher","first-page":"155798832097763","DOI":"10.1177\/1557988320977630","volume":"14","author":"C-C Chen","year":"2020","unstructured":"Chen C-C, Hsueh K-C, Shen C-H, Bai C-H, Wu C-C, Wang Y-H. The diagnostic value of p16\/ki67 dual immunostaining for anal intraepithelial neoplasia: a meta-analysis. Am J Mens Health. 2020;14(6):1557988320977630.","journal-title":"Am J Mens Health"},{"issue":"7","key":"6470_CR248","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/01.pas.0000208283.14044.a9","volume":"30","author":"AE Walts","year":"2006","unstructured":"Walts AE, Lechago J, Bose S. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia. Am J Surg Pathol. 2006;30(7):795\u2013801.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"6470_CR249","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.31557\/APJCP.2019.20.10.3043","volume":"20","author":"G Kaur","year":"2019","unstructured":"Kaur G, Balasubramaniam SD, Lee YJ, Balakrishnan V, Oon CE. Minichromosome maintenance complex (MCM) genes profiling and MCM2 protein expression in cervical cancer development. Asian Pac J Cancer Prev. 2019;20(10):3043\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"6470_CR250","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3892\/ol.2017.5650","volume":"13","author":"C Scapulatempo-Neto","year":"2017","unstructured":"Scapulatempo-Neto C, Veo C, Fregnani J, Lorenzi A, Mafra A, Melani AGF, et al. Characterization of topoisomerase II \u03b1 and minichromosome maintenance protein 2 expression in anal carcinoma. Oncol Lett. 2017;13(3):1891\u20138.","journal-title":"Oncol Lett"},{"issue":"4","key":"6470_CR251","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.5301\/jbm.5000081","volume":"29","author":"SM Amaro Filho","year":"2014","unstructured":"Amaro Filho SM, Nuovo GJ, Cunha CB, Ramos Pereira Lde O, Oliveira-Silva M, Russomano F, et al. Correlation of MCM2 detection with stage and virology of cervical cancer. Int J Biol Markers. 2014;29(4):e363\u201371.","journal-title":"Int J Biol Markers"},{"key":"6470_CR252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-021-02448-3","volume":"19","author":"C Ran","year":"2021","unstructured":"Ran C, Sun J, Qu Y, Long N. Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer. World J Surg Oncol. 2021;19:1\u201311.","journal-title":"World J Surg Oncol"},{"issue":"12","key":"6470_CR253","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.3390\/cancers12123730","volume":"12","author":"P Charkhchi","year":"2020","unstructured":"Charkhchi P, Cybulski C, Gronwald J, Wong FO, Narod SA, Akbari MR. CA125 and ovarian cancer: a comprehensive review. Cancers. 2020;12(12):3730.","journal-title":"Cancers"},{"issue":"5","key":"6470_CR254","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.4103\/jcrt.jcrt_335_21","volume":"19","author":"V Tony","year":"2023","unstructured":"Tony V, Sathyamurthy A, Ramireddy JK, Iswarya SJ, Gowri SM, Thomas A, et al. Role of squamous cell carcinoma antigen in prognostication, monitoring of treatment response, and surveillance of locally advanced cervical carcinoma. J Cancer Res Ther. 2023;19(5):1236\u201340.","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"6470_CR255","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ygyno.2016.07.006","volume":"142","author":"NA Wijetunga","year":"2016","unstructured":"Wijetunga NA, Belbin TJ, Burk RD, Whitney K, Abadi M, Greally JM, et al. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia. Gynecol Oncol. 2016;142(3):566\u201373.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"6470_CR256","doi-asserted-by":"publisher","first-page":"E638","DOI":"10.1002\/ijc.29196","volume":"136","author":"K Louvanto","year":"2015","unstructured":"Louvanto K, Franco EL, Ramanakumar AV, Vasiljevi\u0107 N, Scibior-Bentkowska D, Koushik A, et al. Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. Int J Cancer. 2015;136(6):E638\u201345.","journal-title":"Int J Cancer"},{"issue":"3","key":"6470_CR257","doi-asserted-by":"publisher","first-page":"e0122495","DOI":"10.1371\/journal.pone.0122495","volume":"10","author":"EM Siegel","year":"2015","unstructured":"Siegel EM, Riggs BM, Delmas AL, Koch A, Hakam A, Brown KD. Quantitative DNA methylation analysis of candidate genes in cervical cancer. PLoS ONE. 2015;10(3):e0122495.","journal-title":"PLoS ONE"},{"issue":"6","key":"6470_CR258","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3892\/etm.2021.10916","volume":"22","author":"A Albulescu","year":"2021","unstructured":"Albulescu A, Plesa A, Fudulu A, Iancu IV, Anton G, Botezatu A. Epigenetic approaches for cervical neoplasia screening (Review). Exp Ther Med. 2021;22(6):1481.","journal-title":"Exp Ther Med"},{"issue":"4","key":"6470_CR259","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jnci\/dji041","volume":"97","author":"Q Feng","year":"2005","unstructured":"Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst. 2005;97(4):273\u201382.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"6470_CR260","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13148-024-01669-z","volume":"16","author":"MJ Fackler","year":"2024","unstructured":"Fackler MJ, Pleas M, Li Y, Soni A, Xing D, Cope L, et al. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries. Clin Epigenetics. 2024;16(1):56.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"6470_CR261","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13148-019-0765-3","volume":"11","author":"PL Liew","year":"2019","unstructured":"Liew PL, Huang RL, Wu TI, Liao CC, Chen CW, Su PH, et al. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings. Clin Epigenetics. 2019;11(1):170.","journal-title":"Clin Epigenetics"},{"key":"6470_CR262","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.micpath.2012.11.002","volume":"58","author":"CL Pang","year":"2013","unstructured":"Pang CL, Thierry F. Human papillomavirus proteins as prospective therapeutic targets. Microb Pathog. 2013;58:55\u201365.","journal-title":"Microb Pathog"},{"issue":"1","key":"6470_CR263","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/s41467-024-45920-w","volume":"15","author":"JCK Wang","year":"2024","unstructured":"Wang JCK, Baddock HT, Mafi A, Foe IT, Bratkowski M, Lin TY, et al. Structure of the p53 degradation complex from HPV16. Nat Commun. 2024;15(1):1842.","journal-title":"Nat Commun"},{"key":"6470_CR264","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2019.10.046","volume":"470","author":"M Celegato","year":"2020","unstructured":"Celegato M, Messa L, Goracci L, Mercorelli B, Bertagnin C, Spyrakis F, et al. A novel small-molecule inhibitor of the human papillomavirus E6\u2013p53 interaction that reactivates p53 function and blocks cancer cells growth. Cancer Lett. 2020;470:115\u201325.","journal-title":"Cancer Lett"},{"issue":"1","key":"6470_CR265","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/cancers14010193","volume":"14","author":"M Celegato","year":"2021","unstructured":"Celegato M, Messa L, Bertagnin C, Mercorelli B, Loregian A. Targeted disruption of E6\/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against HPV-transformed cancer cells. Cancers (Basel). 2021;14(1):193.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6470_CR266","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41467-021-21258-5","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Blayney A, Liu X, Gandy L, Jin W, Yan L, et al. EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction. Nat Commun. 2021;12(1):986.","journal-title":"Nat Commun"},{"key":"6470_CR267","doi-asserted-by":"publisher","first-page":"106128","DOI":"10.1016\/j.phrs.2022.106128","volume":"177","author":"J Zhang","year":"2022","unstructured":"Zhang J, Yu G, Yang Y, Wang Y, Guo M, Yin Q, et al. A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6\u2013E6AP-p53 axis. Pharmacol Res. 2022;177:106128.","journal-title":"Pharmacol Res"},{"issue":"2","key":"6470_CR268","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets. Nat Rev Drug Discov. 2023;22(2):127\u201344.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"6470_CR269","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"6470_CR270","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/cgt.2010.38","volume":"17","author":"JT Chang","year":"2010","unstructured":"Chang JT, Kuo TF, Chen YJ, Chiu CC, Lu YC, Li HF, et al. Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers. Cancer Gene Ther. 2010;17(12):827\u201336.","journal-title":"Cancer Gene Ther"},{"issue":"sup2","key":"6470_CR271","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/21691401.2018.1468770","volume":"46","author":"H Javadi","year":"2018","unstructured":"Javadi H, Lotfi AS, Hosseinkhani S, Mehrani H, Amani J, Soheili ZS, et al. The combinational effect of E6\/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells. Artif Cells Nanomed Biotechnol. 2018;46(sup2):727\u201336.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"14","key":"6470_CR272","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/sj.onc.1209244","volume":"25","author":"S Tang","year":"2006","unstructured":"Tang S, Tao M, McCoy JP Jr, Zheng ZM. Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene. 2006;25(14):2094\u2013104.","journal-title":"Oncogene"},{"key":"6470_CR273","doi-asserted-by":"publisher","first-page":"677867","DOI":"10.3389\/fcell.2021.677867","volume":"9","author":"J Zhu","year":"2021","unstructured":"Zhu J, Kamara S, Wang Q, Guo Y, Li Q, Wang L, et al. Novel affibody molecules targeting the HPV16 E6 oncoprotein inhibited the proliferation of cervical cancer cells. Front Cell Dev Biol. 2021;9:677867.","journal-title":"Front Cell Dev Biol"},{"key":"6470_CR274","doi-asserted-by":"publisher","first-page":"108684","DOI":"10.1016\/j.clim.2021.108684","volume":"225","author":"W Zhang","year":"2021","unstructured":"Zhang W, Shan H, Jiang K, Huang W, Li S. A novel intracellular nanobody against HPV16 E6 oncoprotein. Clin Immunol. 2021;225:108684.","journal-title":"Clin Immunol"},{"issue":"2","key":"6470_CR275","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bbrc.2007.07.040","volume":"361","author":"M Lagrange","year":"2007","unstructured":"Lagrange M, Boulade-Ladame C, Mailly L, Weiss E, Orfanoudakis G, Deryckere F. Intracellular scFvs against the viral E6 oncoprotein provoke apoptosis in human papillomavirus-positive cancer cells. Biochem Biophys Res Commun. 2007;361(2):487\u201392.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"6470_CR276","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jmb.2005.10.077","volume":"355","author":"H Griffin","year":"2006","unstructured":"Griffin H, Elston R, Jackson D, Ansell K, Coleman M, Winter G, et al. Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting. J Mol Biol. 2006;355(3):360\u201378.","journal-title":"J Mol Biol"},{"issue":"1","key":"6470_CR277","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/cddis.2015.391","volume":"7","author":"CH Yuan","year":"2016","unstructured":"Yuan CH, Filippova M, Krstenansky JL, Duerksen-Hughes PJ. Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV\u207a cells. Cell Death Dis. 2016;7(1):2060.","journal-title":"Cell Death Dis"},{"issue":"11","key":"6470_CR278","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1517\/14728222.2013.832204","volume":"17","author":"J Manzo-Merino","year":"2013","unstructured":"Manzo-Merino J, Thomas M, Fuentes-Gonzalez AM, Lizano M, Banks L. HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers. Expert Opin Ther Targets. 2013;17(11):1357\u201368.","journal-title":"Expert Opin Ther Targets"},{"issue":"8","key":"6470_CR279","first-page":"4918","volume":"13","author":"JM Huibregtse","year":"1993","unstructured":"Huibregtse JM, Scheffner M, Howley PM. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol. 1993;13(8):4918\u201327.","journal-title":"Mol Cell Biol"},{"issue":"22","key":"6470_CR280","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1074\/jbc.273.22.13537","volume":"273","author":"JJ Chen","year":"1998","unstructured":"Chen JJ, Hong Y, Rustamzadeh E, Baleja JD, Androphy EJ. Identification of an alpha helical motif sufficient for association with papillomavirus E6. J Biol Chem. 1998;273(22):13537\u201344.","journal-title":"J Biol Chem"},{"issue":"12","key":"6470_CR281","doi-asserted-by":"publisher","first-page":"e84506","DOI":"10.1371\/journal.pone.0084506","volume":"8","author":"JJ Cherry","year":"2013","unstructured":"Cherry JJ, Rietz A, Malinkevich A, Liu Y, Xie M, Bartolowits M, et al. Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function. PLoS ONE. 2013;8(12):e84506.","journal-title":"PLoS ONE"},{"issue":"7","key":"6470_CR282","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1021\/cb500229d","volume":"9","author":"KA Malecka","year":"2014","unstructured":"Malecka KA, Fera D, Schultz DC, Hodawadekar S, Reichman M, Donover PS, et al. Identification and characterization of small molecule human papillomavirus E6 inhibitors. ACS Chem Biol. 2014;9(7):1603\u201312.","journal-title":"ACS Chem Biol"},{"issue":"27","key":"6470_CR283","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1002\/anie.201502646","volume":"54","author":"J Ramirez","year":"2015","unstructured":"Ramirez J, Poirson J, Foltz C, Chebaro Y, Schrapp M, Meyer A, et al. Targeting the two oncogenic functional sites of the HPV E6 oncoprotein with a high-affinity bivalent ligand. Angew Chem Int Ed Engl. 2015;54(27):7958\u201362.","journal-title":"Angew Chem Int Ed Engl"},{"key":"6470_CR284","doi-asserted-by":"publisher","first-page":"519619","DOI":"10.1155\/2013\/519619","volume":"2013","author":"ML Tornesello","year":"2013","unstructured":"Tornesello ML, Buonaguro L, Giorgi-Rossi P, Buonaguro FM. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. Biomed Res Int. 2013;2013:519619.","journal-title":"Biomed Res Int"},{"issue":"1","key":"6470_CR285","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.antiviral.2006.03.014","volume":"72","author":"JD Baleja","year":"2006","unstructured":"Baleja JD, Cherry JJ, Liu Z, Gao H, Nicklaus MC, Voigt JH, et al. Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antiviral Res. 2006;72(1):49\u201359.","journal-title":"Antiviral Res"},{"issue":"9","key":"6470_CR286","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/cncr.29925","volume":"122","author":"M Reuschenbach","year":"2016","unstructured":"Reuschenbach M, Pauligk C, Karbach J, Rafiyan MR, Kloor M, Prigge ES, et al. A phase 1\/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers. Cancer. 2016;122(9):1425\u201333.","journal-title":"Cancer"},{"issue":"4","key":"6470_CR287","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2165\/00063030-200620040-00002","volume":"20","author":"KL Green","year":"2006","unstructured":"Green KL, Gaston K. Development of a topical protein therapeutic for human papillomavirus and associated cancers. BioDrugs. 2006;20(4):209\u201318.","journal-title":"BioDrugs"},{"issue":"5\u20136","key":"6470_CR288","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/hum.2019.246","volume":"31","author":"K Ling","year":"2020","unstructured":"Ling K, Yang L, Yang N, Chen M, Wang Y, Liang S, et al. Gene targeting of HPV18 E6 and E7 synchronously by nonviral transfection of CRISPR\/Cas9 system in cervical cancer. Hum Gene Ther. 2020;31(5\u20136):297\u2013308.","journal-title":"Hum Gene Ther"},{"issue":"6","key":"6470_CR289","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157(6):1262\u201378.","journal-title":"Cell"},{"issue":"20","key":"6470_CR290","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1128\/JVI.01879-14","volume":"88","author":"EM Kennedy","year":"2014","unstructured":"Kennedy EM, Kornepati AV, Goldstein M, Bogerd HP, Poling BC, Whisnant AW, et al. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease. J Virol. 2014;88(20):11965\u201372.","journal-title":"J Virol"},{"key":"6470_CR291","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.omto.2021.12.011","volume":"24","author":"R Tian","year":"2022","unstructured":"Tian R, Liu J, Fan W, Li R, Cui Z, Jin Z, et al. Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6\/E7 genes in cervical cancer cells. Mol Ther Oncolytics. 2022;24:171\u20139.","journal-title":"Mol Ther Oncolytics"},{"issue":"6","key":"6470_CR292","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/17425247.2020.1747429","volume":"17","author":"S Aghamiri","year":"2020","unstructured":"Aghamiri S, Talaei S, Roshanzamiri S, Zandsalimi F, Fazeli E, Aliyu M, et al. Delivery of genome editing tools: a promising strategy for HPV-related cervical malignancy therapy. Expert Opin Drug Deliv. 2020;17(6):753\u201366.","journal-title":"Expert Opin Drug Deliv"},{"key":"6470_CR293","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.omtm.2020.06.022","volume":"18","author":"MPT Ernst","year":"2020","unstructured":"Ernst MPT, Broeders M, Herrero-Hernandez P, Oussoren E, van der Ploeg AT, Pijnappel W. Ready for repair? Gene editing enters the clinic for the treatment of human disease. Mol Ther Methods Clin Dev. 2020;18:532\u201357.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"10103","key":"6470_CR294","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0140-6736(17)31607-0","volume":"390","author":"KS Tewari","year":"2017","unstructured":"Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, Landrum LM, et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017;390(10103):1654\u201363.","journal-title":"Lancet"},{"key":"6470_CR295","doi-asserted-by":"publisher","first-page":"200238","DOI":"10.1016\/j.tvr.2022.200238","volume":"13","author":"CA Burmeister","year":"2022","unstructured":"Burmeister CA, Khan SF, Sch\u00e4fer G, Mbatani N, Adams T, Moodley J, et al. Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Res. 2022;13:200238.","journal-title":"Tumour Virus Res"},{"key":"6470_CR296","doi-asserted-by":"publisher","first-page":"612547","DOI":"10.3389\/fimmu.2020.612547","volume":"11","author":"W Chen","year":"2020","unstructured":"Chen W, Zhang Y, Zhao C, Shao S, Zhang Y, Li X, et al. Nocardia rubra cell wall skeleton up-regulates T cell subsets and inhibits PD-1\/PD-L1 pathway to promote local immune status of patients with high-risk human papillomavirus infection and cervical intraepithelial neoplasia. Front Immunol. 2020;11:612547.","journal-title":"Front Immunol"},{"key":"6470_CR297","doi-asserted-by":"publisher","first-page":"984896","DOI":"10.3389\/fonc.2022.984896","volume":"12","author":"Y Xie","year":"2022","unstructured":"Xie Y, Kong W, Zhao X, Zhang H, Luo D, Chen S. Immune checkpoint inhibitors in cervical cancer: current status and research progress. Front Oncol. 2022;12:984896.","journal-title":"Front Oncol"},{"issue":"20","key":"6470_CR298","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","volume":"385","author":"N Colombo","year":"2021","unstructured":"Colombo N, Dubot C, Lorusso D, Caceres MV, Hasegawa K, Shapira-Frommer R, et al. Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. N Engl J Med. 2021;385(20):1856\u201367.","journal-title":"N Engl J Med"},{"issue":"14","key":"6470_CR299","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1200\/JCO.2014.58.9093","volume":"33","author":"S Stevanovi\u0107","year":"2015","unstructured":"Stevanovi\u0107 S, Draper LM, Langhan MM, Campbell TE, Kwong ML, Wunderlich JR, et al. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. J Clin Oncol. 2015;33(14):1543\u201350.","journal-title":"J Clin Oncol"},{"key":"6470_CR300","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1182\/blood-2018-99-117017","volume":"132","author":"SM Norberg","year":"2018","unstructured":"Norberg SM, Nagarsheth N, Doran S, Kanakry JA, Adhikary S, Schweitzer C, et al. Regression of epithelial cancers following T cell receptor gene therapy targeting human papillomavirus-16 E7. Blood. 2018;132:492.","journal-title":"Blood"},{"key":"6470_CR301","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99488","author":"BY Jin","year":"2018","unstructured":"Jin BY, Campbell TE, Draper LM, Stevanovi\u0107 S, Weissbrich B, Yu Z, et al. Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model. JCI Insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.99488.","journal-title":"JCI Insight"},{"issue":"19","key":"6470_CR302","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1158\/1078-0432.CCR-14-3341","volume":"21","author":"LM Draper","year":"2015","unstructured":"Draper LM, Kwong ML, Gros A, Stevanovi\u0107 S, Tran E, Kerkar S, et al. Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6. Clin Cancer Res. 2015;21(19):4431\u20139.","journal-title":"Clin Cancer Res"},{"key":"6470_CR303","volume-title":"Genital Warts","author":"SW Leslie","year":"2024","unstructured":"Leslie SW, Sajjad H, Kumar S. Genital Warts. Treasure Island: StatPearls Publishing; 2024."},{"key":"6470_CR304","doi-asserted-by":"publisher","first-page":"1386167","DOI":"10.3389\/fonc.2024.1386167","volume":"14","author":"JC Gonz\u00e1lez-Rodr\u00edguez","year":"2024","unstructured":"Gonz\u00e1lez-Rodr\u00edguez JC, Cruz-Valdez A, Madrid-Marina V. Cervical cancer prevention by vaccination: review. Front Oncol. 2024;14:1386167.","journal-title":"Front Oncol"},{"key":"6470_CR305","unstructured":"HPV Vaccination: What Everyone Should Know|CDC. https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/public\/index.html. Accessed 14 Apr 2025."},{"issue":"5","key":"6470_CR306","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.3802\/jgo.2016.27.e51","volume":"27","author":"SJ Lee","year":"2016","unstructured":"Lee SJ, Yang A, Wu TC, Hung CF. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. J Gynecol Oncol. 2016;27(5):e51.","journal-title":"J Gynecol Oncol"},{"key":"6470_CR307","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2147\/IJWH.S50365","volume":"6","author":"R De Vincenzo","year":"2014","unstructured":"De Vincenzo R, Conte C, Ricci C, Scambia G, Capelli G. Long-term efficacy and safety of human papillomavirus vaccination. Int J Womens Health. 2014;6:999\u20131010.","journal-title":"Int J Womens Health"},{"key":"6470_CR308","unstructured":"Human Papillomavirus Vaccines: WHO Position Paper. 2022. https:\/\/www.who.int\/publications\/i\/item\/who-wer9750-645-672. Accessed 14 Apr 2025."},{"issue":"4","key":"6470_CR309","doi-asserted-by":"publisher","first-page":"pky045","DOI":"10.1093\/jncics\/pky045","volume":"2","author":"S de Sanjos\u00e9","year":"2018","unstructured":"de Sanjos\u00e9 S, Serrano B, Tous S, Alejo M, Lloveras B, Quir\u00f3s B, et al. Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58. JNCI Cancer Spectr. 2018;2(4):pky045.","journal-title":"JNCI Cancer Spectr"},{"issue":"1\u20132","key":"6470_CR310","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.virol.2013.07.020","volume":"445","author":"M Bergvall","year":"2013","unstructured":"Bergvall M, Melendy T, Archambault J. The E1 proteins. Virology. 2013;445(1\u20132):35\u201356.","journal-title":"Virology"},{"issue":"7","key":"6470_CR311","doi-asserted-by":"publisher","first-page":"918","DOI":"10.7326\/M21-3798","volume":"175","author":"HG Rosenblum","year":"2022","unstructured":"Rosenblum HG, Lewis RM, Gargano JW, Querec TD, Unger ER, Markowitz LE. Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the United States, 2003 to 2018. Ann Intern Med. 2022;175(7):918\u201326.","journal-title":"Ann Intern Med"},{"issue":"1\u20132","key":"6470_CR312","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.virol.2013.06.006","volume":"445","author":"AA McBride","year":"2013","unstructured":"McBride AA. The papillomavirus E2 proteins. Virology. 2013;445(1\u20132):57\u201379.","journal-title":"Virology"},{"issue":"1\u20132","key":"6470_CR313","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.virol.2013.07.008","volume":"445","author":"J Doorbar","year":"2013","unstructured":"Doorbar J. The E4 protein; structure, function and patterns of expression. Virology. 2013;445(1\u20132):80\u201398.","journal-title":"Virology"},{"issue":"6338","key":"6470_CR314","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/352824a0","volume":"352","author":"J Doorbar","year":"1991","unstructured":"Doorbar J, Ely S, Sterling J, McLean C, Crawford L. Specific interaction between HPV-16 E1\u2013E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature. 1991;352(6338):824\u20137.","journal-title":"Nature"},{"issue":"Pt 16","key":"6470_CR315","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1242\/jcs.061978","volume":"123","author":"PB McIntosh","year":"2010","unstructured":"McIntosh PB, Laskey P, Sullivan K, Davy C, Wang Q, Jackson DJ, et al. E1\u2013E4-mediated keratin phosphorylation and ubiquitylation: a mechanism for keratin depletion in HPV16-infected epithelium. J Cell Sci. 2010;123(Pt 16):2810\u201322.","journal-title":"J Cell Sci"},{"issue":"1\u20132","key":"6470_CR316","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.virol.2013.05.006","volume":"445","author":"D DiMaio","year":"2013","unstructured":"DiMaio D, Petti LM. The E5 proteins. Virology. 2013;445(1\u20132):99\u2013114.","journal-title":"Virology"},{"issue":"1\u20132","key":"6470_CR317","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.virol.2013.04.026","volume":"445","author":"SB Vande Pol","year":"2013","unstructured":"Vande Pol SB, Klingelhutz AJ. Papillomavirus E6 oncoproteins. Virology. 2013;445(1\u20132):115\u201337.","journal-title":"Virology"},{"issue":"1\u20132","key":"6470_CR318","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","volume":"445","author":"A Roman","year":"2013","unstructured":"Roman A, Munger K. The papillomavirus E7 proteins. Virology. 2013;445(1\u20132):138\u201368.","journal-title":"Virology"},{"issue":"5","key":"6470_CR319","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3390\/v14050953","volume":"14","author":"F Kuehner","year":"2022","unstructured":"Kuehner F, Stubenrauch F. Functions of papillomavirus E8^E2 proteins in tissue culture and in vivo. Viruses. 2022;14(5):953.","journal-title":"Viruses"},{"issue":"1\u20132","key":"6470_CR320","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.virol.2013.05.038","volume":"445","author":"CB Buck","year":"2013","unstructured":"Buck CB, Day PM, Trus BL. The papillomavirus major capsid protein L1. Virology. 2013;445(1\u20132):169\u201374.","journal-title":"Virology"},{"issue":"1\u20132","key":"6470_CR321","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","volume":"445","author":"JW Wang","year":"2013","unstructured":"Wang JW, Roden RB. L2, the minor capsid protein of papillomavirus. Virology. 2013;445(1\u20132):175\u201386.","journal-title":"Virology"},{"issue":"5","key":"6470_CR322","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1177\/147323001003800518","volume":"38","author":"Y Li","year":"2010","unstructured":"Li Y, Liu J, Yuan C, Cui B, Zou X, Qiao Y. High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia. J Int Med Res. 2010;38(5):1730\u20136.","journal-title":"J Int Med Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06470-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06470-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:04:13Z","timestamp":1745910253000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06470-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":322,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6470"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06470-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"483"}}